Firsthand Technology Value Fund (SVVC) 10-Q/A 17 May 23 2023 Q1 Quarterly report (amended) Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2023 shares
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Amendment Description	Amendment No 1
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	333-168195
Entity Registrant Name	FIRSTHAND TECHNOLOGY VALUE FUND, INC.
Entity Central Index Key	0001495584
Entity Tax Identification Number	27-3008946
Entity Incorporation, State or Country Code	MD
Entity Address, Address Line One	150 Almaden Boulevard
Entity Address, Address Line Two	Suite 1250
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95113
City Area Code	(408)
Local Phone Number	886-7096
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	6,893,056

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities (Unaudited) - USD ($)		Mar. 31, 2023		Dec. 31, 2022
Investment securities:
Unaffiliated investments at acquisition cost		$ 1,954,831	[1],[2]	$ 1,772,422
Affiliated investments at acquisition cost		662,235		662,235
Controlled investments at acquisition cost		132,091,932		140,355,353
Total acquisition cost		134,708,998		142,790,010
Unaffiliated investments at market value		954,831	[1],[2]	772,422
Affiliated investments at market value		202,672		337,500
Controlled investments at market value		34,204,332		39,012,002
Total Market value* (Note 6)	[1],[2]	35,361,835		40,121,924
Foreign currency at value (cost $3,235 and $3,235)		3,342		3,404
Receivable from dividends and interest		182,777		14,463
Other assets		72,629		64,066
Total Assets		35,620,583		40,203,857
LIABILITIES
Due to Custodian		10,000		0
Payable to affiliates (Note 4)		9,410,294		9,188,187
Trustees’ fees payable		50,000		50,000
Consulting fee payable		66,000		46,000
Accrued expenses and other payables		216,922		310,079
Total Liabilities		9,753,216		9,594,266
NET ASSETS		25,867,367		30,609,591
Net Assets consist of:
Common Stock, par value $0.001 per share 100,000,000 shares authorized		6,893		6,893
Paid-in-capital		176,770,722		176,770,722
Total distributable earnings (loss)		(150,910,248)		(146,168,024)
Shares of Common Stock outstanding		$ 7,016,432		$ 7,016,432
Shares of Treasury Stock outstanding		(123,376)		(123,376)
Total Shares of Common Stock outstanding		6,893,056		6,893,056
Net asset value per share (Note 2)		$ 3.75		$ 4.44
[1]Includes Fidelity Investment Money Market Treasury Portfolio - Class I, which invests primarily in U.S. Treasury securities. The yields as of 03/31/23 and 12/31/22 were 4.70% and 4.13%, respectively. Please see https://fundresearch.fidelity.com/mutual-funds/summary/316175504 for additional information.[2]Includes warrants whose primary risk exposure is equity contracts.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Unaudited) (Parenthetical) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Consolidated Statements Of Assets And Liabilities Unaudited
Foreign currency cost	$ 3,235	$ 3,235
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
INVESTMENT INCOME
Unaffiliated interest		$ 42,279	$ 35,238
Affiliated/controlled interest		148,983	1,901,052
TOTAL INVESTMENT INCOME		191,262	1,936,290
EXPENSES
Investment advisory fees (Note 4)		192,820	489,772
Administration fees		28,503	29,579
Custody fees		2,160	5,807
Transfer agent fees		7,878	9,977
Registration and filing fees		8,704	8,334
Professional fees		65,769	69,222
Printing fees		14,548	18,740
Trustees fees		18,750	50,000
Compliance fees		29,288	29,287
Miscellaneous fees		20,931	22,147
TOTAL GROSS EXPENSES		389,351	732,865
NET INVESTMENT INCOME		(198,089)	1,203,425
Net realized gains (losses) from security transactions on:
Affiliated/controlled		(7,864,997)	183,913
Foreign currency		0	2,660
Net realized gains (losses)		(7,864,997)	186,573
Net change in unrealized appreciation (depreciation) on:
Non-affiliated investments		0	191,876
Affiliated/controlled investments and foreign currency		2,557,271	(9,037,774)
Affiliated/controlled warrants investments	[1]	763,591	105,958
Net change in unrealized appreciation (depreciation)		3,320,862	(8,739,940)
Net Realized and Unrealized (Loss) on Investments		(4,544,135)	(8,553,367)
Net Decrease In Net Assets Resulting From Operations		$ (4,742,224)	$ (7,349,942)
Net Decrease In Net Assets Per Share Resulting From Operations	[2]	$ (0.69)	$ (1.07)
[1]Primary exposure is equity risk.[2]Per share results are calculated based on weighted average shares outstanding for each period.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net increase (decrease) in Net Assets resulting from operations	$ (4,742,224)	$ (7,349,942)
Adjustments to reconcile net increase (decrease) in Net Assets derived from operations to net cash provided by (used in) operating activities
Proceeds from disposition of investments	498,424	808,955
Net purchases/sales from short-term investments	(282,470)	(426,644)
Increase (decrease) in dividends, interest, and reclaims receivable	(168,314)	(1,824,186)
Increase (decrease) in due to Custodian	10,000	0
Increase (decrease) in receivable in investment sold	0	(339,624)
Increase (decrease) in payable to affiliates	222,107	519,060
Increase (decrease) in other assets	(8,563)	(8,233)
Increase (decrease) in accrued expenses and other payables	(73,157)	131,388
Net realized gain (loss) from investments	7,864,997	(186,573)
Net unrealized appreciation (depreciation) from investments, other assets, and warrants transactions	(3,320,862)	8,739,940
Net cash provided by (used in) operating activities	(62)	64,141
CASH FLOWS FROM FINANCING ACTIVITIES
Net cash provided by (used in) financing activities	0	0
Net increase (decrease) in cash	(62)	64,141
Cash and foreign currency - beginning of period	3,404	0
Cash and foreign currency - end of period	$ 3,342	$ 64,141

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
FROM OPERATIONS:
Net investment income	$ (198,089)	$ 1,203,425
Net realized gain (loss) from security transactions and foreign currency	(7,864,997)	186,573
Net change in unrealized appreciation (depreciation) on investments, other assets, and warrants transactions	3,320,862	(8,739,940)
Net decrease in net assets from operations	(4,742,224)	(7,349,942)
TOTAL DECREASE IN NET ASSETS	(4,742,224)	(7,349,942)
NET ASSETS:
Beginning of period	30,609,591	94,754,624
End of period	25,867,367	87,404,682
COMMON STOCK ACTIVITY:
Shares repurchased	0	0
Net increase in shares outstanding	$ 0	$ 0
Shares outstanding, beginning of period	6,893,056	6,893,056
Shares outstanding, end of period	6,893,056	6,893,056

Consolidated Financial Highligh

Consolidated Financial Highlights - USD ($) $ in Millions		3 Months Ended		12 Months Ended
		Mar. 31, 2023		Dec. 31, 2022	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Fair Value Disclosures [Abstract]
Net asset value at beginning of period		$ 4.44		$ 13.75	$ 14.82		$ 17.70		$ 26.69		$ 23.83
Income from investment operations:
Net investment income (loss), before deferred taxes		(0.03)		(1.81)	0.44	[1]	0.09	[1]	0.90	[1]	(1.29)	[1]
Deferred tax benefit									(0.08)		0.07
Net investment gain (losses)		(0.03)		(1.81)	0.44		0.09		0.82		(1.22)
Net realized and unrealized gains (losses) on investments, before deferred taxes		(0.66)		(7.50)	(1.51)		(2.30)		(12.15)		5.13
Deferred tax expense							(1.13)		2.34		(1.23)
Net realized and unrealized gains (losses) on investments, after deferred taxes		(0.66)		(7.50)	(1.51)		(3.43)		(9.81)		3.90
Total from investment operations		(0.69)		(9.31)	(1.07)		(3.34)		(8.99)		2.68
Realized capital gains											(0.03)
Anti-dilutive effect from capital share transactions							0.46				0.21
Net asset value at end of period		3.75		4.44	13.75		14.82		17.70		26.69
Market value at end of period		$ 0.95		$ 0.95	$ 4.01		$ 4.47		$ 6.43		$ 11.20
Based on Net Asset Value		(15.54%)	[2]	(67.71%)	(7.22%)		(16.27%)		(33.68%)		12.39%
Based on Market Value			[2]	(76.31%)	(10.29%)		(30.48%)		(42.59%)		25.43%
Net assets at end of period (millions)		$ 25.9		$ 30.6	$ 94.8		$ 102.1		$ 127.1		$ 191.6
Ratio of total expenses to average net assets:
Before tax (benefit)/expense		5.59%	[3]	4.11%	3.12%		3.10%		(2.84%)	[4]	6.75%	[4]
Deferred tax (benefit)/expense	[5],[6]						8.02%	[7]	(9.91%)		4.43%
Total expenses		5.59%	[3]	4.11%	3.12%		11.12%		(12.75%)	[4]	11.18%	[4]
Total expenses, excluding incentive fees and deferred tax expense		5.59%	[3]	4.11%	3.12%		3.10%		2.80%		2.77%
Ratio of net investment income (loss) to average net assets:
Before tax benefit		(2.84%)	[3]	(20.96%)	2.94%		0.64%		3.93%	[4]	(4.93%)	[4]
Deferred tax benefit	[6],[8]								(0.33%)		0.28%
Net investment income (loss)		(2.84%)	[3]	(20.96%)	2.94%		0.64%		3.60%		(4.65%)
Portfolio turnover rate		0%	[2]	15%	16%		13%		18%		44%
[1]Calculated using average shares outstanding.[2]Not Annualized.[3]Annualized.[4]Amount includes the incentive fee. For the years ended December 31, 2019, December 31, 2018 and December 31, 2017 the ratio of the incentive fee to average net assets was (5.64)%, 3.98% and 1.15% respectively.[5]Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses).[6]The deferred tax expense and tax benefit are based on average net assets.[7]As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense.[8]Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only.

Consolidated Schedule of Invest

Consolidated Schedule of Investments - USD ($)		3 Months Ended		12 Months Ended
		Mar. 31, 2023		Dec. 31, 2022
Net Investment Income [Line Items]
VALUE		$ 28,125,998		$ 35,929,006
TOTAL INVESTMENTS		35,361,835		40,121,924
LIABILITIES IN EXCESS OF OTHER ASSETS		(9,494,468)		(9,512,333)
Net assets		$ 25,867,367		$ 30,609,591
Eqx Capital Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Common Stock *(1)(2)(4)	[1],[2],[3],[4]	Common Stock *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Jun. 10, 2016		Jun. 10, 2016
SHARES/PAR VALUE		100,000		100,000
COST BASIS		$ 20,000		$ 20,000
VALUE		$ 3,210		$ 11,130
Equipment Leasing [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series A *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock - Series A *(1)(2)(4)	[5],[6],[7],[8]
SHARES/PAR VALUE		1,950,000		1,950,000
COST BASIS		$ 1,950,000		$ 1,950,000
VALUE		$ 488,901		$ 865,995
ACQUISITION DATE		6/10/16-11/7/16		6/10/16-11/7/16
Eqx Capital Inc 1 [Member]
Net Investment Income [Line Items]
VALUE		$ 492,111		$ 877,125
Hera Systems Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2024 Interest Rate 5% (1)(2)(4)	[1],[2],[4]	Convertible Note Matures December 2024 Interest Rate 5% (1)(2)(4)	[5],[6],[8]
ACQUISITION DATE		Dec. 29, 2022		Dec. 29, 2022
SHARES/PAR VALUE		1,200,000		1,200,000
COST BASIS		$ 1,200,000		$ 1,200,000
VALUE		$ 1,200,000		$ 1,200,000
Hera Systems Inc 1 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2024 Interest Rate 10% (1)(2)(4)	[1],[2],[4]	Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4)	[5],[6],[8]
ACQUISITION DATE		Dec. 29, 2022		Dec. 29, 2022
SHARES/PAR VALUE		5,359,791		5,359,791
COST BASIS		$ 5,359,791		$ 5,359,791
VALUE		$ 5,359,791		$ 5,359,791
Hera Systems Inc 2 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series A *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock - Series A *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Sep. 18, 2015		Sep. 18, 2015
SHARES/PAR VALUE		3,642,324		3,642,324
COST BASIS		$ 2,000,000		$ 2,000,000
VALUE		$ 19,356		$ 4,735
Hera Systems Inc 3 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series B *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock - Series B *(1)(2)(4)	[5],[6],[7],[8]
SHARES/PAR VALUE		7,039,203		7,039,203
COST BASIS		$ 6,587,102		$ 6,587,102
VALUE		$ 494,279		$ 275,585
ACQUISITION DATE		8/7/17-2/1/19		8/7/17 - 2/1/19
Hera Systems Inc 4 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series C *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock - Series C *(1)(2)(4)	[5],[6],[7],[8]
SHARES/PAR VALUE		2,650,000		2,650,000
COST BASIS		$ 2,650,000		$ 2,650,000
VALUE		$ 186,078		$ 103,748
ACQUISITION DATE		8/7/19-2/12/20		8/7/19-2/12/20
Hera Systems Inc 5 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock Warrants - Series B *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock Warrants - Series B *(1)(2)(4)	[5],[6],[7],[8]
SHARES/PAR VALUE		12,250,000		12,250,000
COST BASIS		$ 0		$ 0
VALUE		$ 859,148		$ 478,608
ACQUISITION DATE		7/9/18-9/4/18		7/9/18 - 9/4/18
Hera Systems Inc 6 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock Warrants - Series B *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock Warrants - Series B *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Feb. 01, 2019		Feb. 01, 2019
SHARES/PAR VALUE		5,250,000		5,250,000
COST BASIS		$ 0		$ 0
VALUE		$ 368,206		$ 205,117
Hera Systems Inc 7 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock Warrants - Series B *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock Warrants - Series B *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Aug. 07, 2017		Aug. 07, 2017
SHARES/PAR VALUE		6,214,922		6,214,922
COST BASIS		$ 0		$ 0
VALUE		$ 435,881		$ 242,817
Hera Systems Inc 8 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock Warrants - Series B *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock Warrants - Series B *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Sep. 28, 2017		Sep. 28, 2017
SHARES/PAR VALUE		700,000		700,000
COST BASIS		$ 0		$ 0
VALUE		49,094		27,349
Hera Systems Inc 9 [Member]
Net Investment Income [Line Items]
VALUE		$ 8,971,833		$ 7,897,750
Intraop Medical Corp [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Dec. 31, 2018		Dec. 31, 2018
SHARES/PAR VALUE		10,961,129		10,961,129
COST BASIS		$ 10,961,129		$ 10,961,129
VALUE		$ 5,642,066		$ 6,746,169
Intraop Medical Corp 1 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jul. 12, 2019		Jul. 12, 2019
SHARES/PAR VALUE		1,300,000		1,300,000
COST BASIS		$ 1,300,000		$ 1,300,000
VALUE		$ 669,154		$ 800,102
Intraop Medical Corp 2 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 11, 2019		Oct. 11, 2019
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,731
Intraop Medical Corp 3 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 29, 2019		Oct. 29, 2019
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,732
Intraop Medical Corp 4 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Feb. 27, 2020		Feb. 27, 2020
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 514,734		$ 615,463
Intraop Medical Corp 5 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Mar. 25, 2020		Mar. 25, 2020
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,732
Intraop Medical Corp 6 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		May 08, 2020		May 08, 2020
SHARES/PAR VALUE		400,000		400,000
COST BASIS		$ 400,000		$ 400,000
VALUE		$ 205,894		$ 246,185
Intraop Medical Corp 7 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jul. 31, 2020		Jul. 31, 2020
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,731
Intraop Medical Corp 8 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Aug. 28, 2020		Aug. 28, 2020
SHARES/PAR VALUE		750,000		750,000
COST BASIS		$ 750,000		$ 750,000
VALUE		$ 386,050		$ 461,597
Intraop Medical Corp 9 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Apr. 20, 2021		Apr. 20, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 514,734		$ 615,463
Intraop Medical Corp 10 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jun. 10, 2021		Jun. 10, 2021
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,732
Intraop Medical Corp 11 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jul. 16, 2021		Jul. 16, 2021
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,732
Intraop Medical Corp 12 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Sep. 22, 2021		Sep. 22, 2021
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,731
Intraop Medical Corp 13 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 06, 2021		Oct. 06, 2021
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,731
Intraop Medical Corp 14 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 22, 2021		Oct. 22, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 514,734		$ 615,463
Intraop Medical Corp 15 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Nov. 12, 2021		Nov. 12, 2021
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,732
Intraop Medical Corp 16 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Nov. 29, 2021		Nov. 29, 2021
SHARES/PAR VALUE		500,000		500,000
COST BASIS		$ 500,000		$ 500,000
VALUE		$ 257,367		$ 307,732
Intraop Medical Corp 17 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Feb. 28, 2022		Feb. 28, 2022
SHARES/PAR VALUE		200,000		200,000
COST BASIS		$ 200,000		$ 200,000
VALUE		$ 102,947		$ 123,093
Intraop Medical Corp 18 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Mar. 30, 2022		Mar. 30, 2022
SHARES/PAR VALUE		150,000		150,000
COST BASIS		$ 150,000		$ 150,000
VALUE		$ 77,210		$ 92,319
Intraop Medical Corp 19 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Apr. 06, 2022		Apr. 06, 2022
SHARES/PAR VALUE		350,000		350,000
COST BASIS		$ 350,000		$ 350,000
VALUE		$ 180,157		$ 215,412
Intraop Medical Corp 20 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures December 2023 Interest Rate 15% (1)(2)(4)	[1],[2],[4]	Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jun. 10, 2022		Jun. 10, 2022
SHARES/PAR VALUE		700,000		700,000
COST BASIS		$ 700,000		$ 700,000
VALUE		$ 360,314		$ 430,824
Intraop Medical Corp 21 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series C *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock - Series C *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Jul. 12, 2013		Jul. 12, 2013
SHARES/PAR VALUE		26,856,187		26,856,187
COST BASIS		$ 26,299,938		$ 26,299,938
VALUE		$ 0		$ 0
Intraop Medical Corp 22 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Term Note Matures December 2023 Interest Rate 8% (1)(2)(4)	[1],[2],[4]	Term Note Matures December 2022 Interest Rate 8% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Feb. 28, 2014		Feb. 28, 2014
SHARES/PAR VALUE		3,000,000		3,000,000
COST BASIS		$ 3,000,000		$ 3,000,000
VALUE		$ 1,544,202		$ 1,846,389
Intraop Medical Corp 23 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Term Note Matures December 2023 Interest Rate 8% (1)(2)(4)	[1],[2],[4]	Term Note Matures December 2022 Interest Rate 8% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Feb. 10, 2017		Feb. 10, 2017
SHARES/PAR VALUE		2,000,000		2,000,000
COST BASIS		$ 2,000,000		$ 2,000,000
VALUE		1,029,468		1,230,926
Intraop Medical Corp 24 [Member]
Net Investment Income [Line Items]
VALUE		$ 14,315,334		$ 17,116,721
Kyma Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures March 2024 Interest Rate 10% (1)(4)	[2],[4]	Convertible Note Matures March 2023 Interest Rate 10% (1)(4)	[6],[8]
ACQUISITION DATE		Mar. 11, 2019		Mar. 11, 2019
SHARES/PAR VALUE		100,000		100,000
COST BASIS		$ 100,000		$ 100,000
VALUE		$ 100,000		$ 100,000
Lyncean Technologies Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series B *(1)(4)	[2],[3],[4]	Preferred Stock - Series B *(1)(4)	[6],[7],[8]
ACQUISITION DATE		Jul. 03, 2018		Jul. 03, 2018
SHARES/PAR VALUE		869,792		869,792
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 0		$ 0
Revasum Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		CDIs *(2)	[1],[3]	CDIs *(2)	[5],[7]
SHARES/PAR VALUE		39,774,889		39,774,889
COST BASIS		$ 9,268,219		$ 9,268,219
VALUE		$ 6,381,006		$ 3,520,496
ACQUISITION DATE		11/14/16-10/3/22		11/14/16 - 10/3/22
Uct Coatings Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Common Stock *(1)(3)(4)	[2],[3],[4],[11]	Common Stock *(1)(3)(4)	[6],[7],[8],[12]
ACQUISITION DATE		Apr. 18, 2011		Apr. 18, 2011
SHARES/PAR VALUE		1,500,000		1,500,000
COST BASIS		$ 662,235		$ 662,235
VALUE		$ 202,672		$ 337,500
Wright Speed Inc [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Common Stock *(1)(2)(4)	[1],[2],[3],[4]	Common Stock *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Jun. 07, 2019
SHARES/PAR VALUE		69,102		69,102
COST BASIS		$ 7,460,851		$ 7,460,851
VALUE		$ 286		$ 546
ACQUISITION DATE				4/11/2013 - 5/6/2019
Wright Speed Inc 1 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jun. 07, 2019		Jun. 07, 2019
SHARES/PAR VALUE		4,929,015		4,929,015
COST BASIS		$ 4,929,015		$ 4,929,015
VALUE		$ 714,707		$ 1,601,930
Wright Speed Inc 2 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Aug. 12, 2020		Aug. 12, 2020
SHARES/PAR VALUE		750,000		750,000
COST BASIS		$ 750,000		$ 750,000
VALUE		$ 108,750		$ 243,750
Wright Speed Inc 3 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Sep. 10, 2020		Sep. 10, 2020
SHARES/PAR VALUE		900,000		900,000
COST BASIS		$ 900,000		$ 900,000
VALUE		$ 130,500		$ 292,500
Wright Speed Inc 4 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 13, 2020		Oct. 13, 2020
SHARES/PAR VALUE		1,050,000		1,050,000
COST BASIS		$ 1,050,000		$ 1,050,000
VALUE		$ 152,250		$ 341,250
Wright Speed Inc 5 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Nov. 11, 2020		Nov. 11, 2020
SHARES/PAR VALUE		400,000		400,000
COST BASIS		$ 400,000		$ 400,000
VALUE		$ 58,000		$ 130,000
Wright Speed Inc 6 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Nov. 24, 2020		Nov. 24, 2020
SHARES/PAR VALUE		375,000		375,000
COST BASIS		$ 375,000		$ 375,000
VALUE		$ 54,375		$ 121,875
Wright Speed Inc 7 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Dec. 11, 2020		Dec. 11, 2020
SHARES/PAR VALUE		400,000		400,000
COST BASIS		$ 400,000		$ 400,000
VALUE		$ 58,000		$ 130,000
Wright Speed Inc 8 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Dec. 23, 2020		Dec. 23, 2020
SHARES/PAR VALUE		2,000,000		2,000,000
COST BASIS		$ 2,000,000		$ 2,000,000
VALUE		$ 290,000		$ 650,000
Wright Speed Inc 9 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Feb. 23, 2021		Feb. 23, 2021
SHARES/PAR VALUE		1,400,000		1,400,000
COST BASIS		$ 1,400,000		$ 1,400,000
VALUE		$ 203,000		$ 455,000
Wright Speed Inc 10 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Apr. 12, 2021		Apr. 12, 2021
SHARES/PAR VALUE		1,200,000		1,200,000
COST BASIS		$ 1,200,000		$ 1,200,000
VALUE		$ 174,000		$ 390,000
Wright Speed Inc 11 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		May 18, 2021		May 18, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 12 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jun. 22, 2021		Jun. 22, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 13 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jul. 26, 2021		Jul. 26, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 14 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Aug. 19, 2021		Aug. 19, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 15 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Sep. 22, 2021		Sep. 22, 2021
SHARES/PAR VALUE		300,000		300,000
COST BASIS		$ 300,000		$ 300,000
VALUE		$ 43,500		$ 97,500
Wright Speed Inc 16 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 05, 2021		Oct. 05, 2021
SHARES/PAR VALUE		700,000		700,000
COST BASIS		$ 700,000		$ 700,000
VALUE		$ 101,500		$ 227,500
Wright Speed Inc 17 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 20, 2021		Oct. 20, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 18 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Nov. 23, 2021		Nov. 23, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 19 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Dec. 28, 2021		Dec. 28, 2021
SHARES/PAR VALUE		1,000,000		1,000,000
COST BASIS		$ 1,000,000		$ 1,000,000
VALUE		$ 145,000		$ 325,000
Wright Speed Inc 20 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Feb. 23, 2022		Feb. 23, 2022
SHARES/PAR VALUE		200,000		200,000
COST BASIS		$ 200,000		$ 200,000
VALUE		$ 29,000		$ 65,000
Wright Speed Inc 21 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Mar. 11, 2022		Mar. 11, 2022
SHARES/PAR VALUE		185,000		185,000
COST BASIS		$ 185,000		$ 185,000
VALUE		$ 26,825		$ 60,125
Wright Speed Inc 22 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Apr. 14, 2022		Apr. 14, 2022
SHARES/PAR VALUE		65,000		65,000
COST BASIS		$ 65,000		$ 65,000
VALUE		$ 9,425		$ 21,125
Wright Speed Inc 23 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		May 10, 2022		May 10, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 24 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		May 26, 2022		May 26, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 25 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jun. 10, 2022		Jun. 10, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 26 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jun. 28, 2022		Jun. 28, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 27 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jul. 13, 2022		Jul. 13, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 28 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Jul. 28, 2022		Jul. 28, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 29 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Aug. 12, 2022		Aug. 12, 2022
SHARES/PAR VALUE		250,000		250,000
COST BASIS		$ 250,000		$ 250,000
VALUE		$ 36,250		$ 81,250
Wright Speed Inc 30 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Oct. 21, 2022		Oct. 21, 2022
SHARES/PAR VALUE		135,000		135,000
COST BASIS		$ 135,000		$ 135,000
VALUE		$ 19,575		$ 43,875
Wright Speed Inc 31 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Nov. 14, 2022		Nov. 14, 2022
SHARES/PAR VALUE		165,000		165,000
COST BASIS		$ 165,000		$ 165,000
VALUE		$ 23,925		$ 53,625
Wright Speed Inc 32 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[5],[6],[8],[10]
ACQUISITION DATE		Dec. 09, 2022		Dec. 09, 2022
SHARES/PAR VALUE		125,000		125,000
COST BASIS		$ 125,000		$ 125,000
VALUE		$ 18,125		$ 40,625
Wright Speed Inc 33 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Convertible Note Matures June 2023 Interest Rate 12% (1)(2)(4)(6)	[1],[2],[4],[9]	Preferred Stock - Series AA *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE		Jan. 10, 2023
SHARES/PAR VALUE		100,000		60,733,693
COST BASIS		$ 100,000		$ 17,355,887
VALUE		$ 14,500		$ 1,049,478
ACQUISITION DATE				6/7/19 - 7/20/20
Wright Speed Inc 34 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Preferred Stock - Series AA *(1)(2)(4)	[1],[2],[3],[4]	Preferred Stock Warrants - Series AA *(1)(2)(4)	[5],[6],[7],[8]
ACQUISITION DATE				Jun. 07, 2019
SHARES/PAR VALUE		60,733,693		609,756
COST BASIS		$ 17,355,887		$ 0
VALUE		$ 543,346		3,232
ACQUISITION DATE		6/7/19-7/20/20
Wright Speed Inc 35 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[1],[2],[3],[4]	Preferred Stock Warrants - Series AA *(1)(2)(4)
ACQUISITION DATE		Jun. 07, 2019
SHARES/PAR VALUE		609,756
COST BASIS		$ 0
VALUE		1,709
Wright Speed Inc 36 [Member]
Net Investment Income [Line Items]
VALUE		$ 4,044,048		$ 8,862,686
Investment Company [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT		Fidelity Investments Money Market Treasury Portfolio - Class I (5)	[13]	Fidelity Investments Money Market Treasury Portfolio - Class I (5)
SHARES/PAR VALUE		854,831		672,422
COST BASIS		$ 854,831		$ 672,422
VALUE		$ 854,831		$ 672,422
ACQUISITION DATE		Various		Various
Silicon Genesis Corp [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Preferred Stock - Series 1-E *(1)(2)(4)
ACQUISITION DATE				Apr. 18, 2011
SHARES/PAR VALUE				5,704,480
COST BASIS				$ 2,372,403
VALUE				$ 320,592
Silicon Genesis Corp 1 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Preferred Stock - Series 1-C *(1)(2)(4)
ACQUISITION DATE				Apr. 18, 2011
SHARES/PAR VALUE				82,914
COST BASIS				$ 109,518
VALUE				$ 962
Silicon Genesis Corp 2 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Preferred Stock - Series 1-D *(1)(2)(4)
ACQUISITION DATE				Apr. 18, 2011
SHARES/PAR VALUE				850,830
COST BASIS				$ 431,901
VALUE				$ 2,552
Silicon Genesis Corp 3 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Common Stock *(1)(2)(4)
ACQUISITION DATE				Apr. 18, 2011
SHARES/PAR VALUE				921,892
COST BASIS				$ 169,045
VALUE				$ 111
Silicon Genesis Corp 4 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Common Stock Warrants *(1)(2)(4)
ACQUISITION DATE				Apr. 18, 2011
SHARES/PAR VALUE				37,982
COST BASIS				$ 6,678
VALUE				$ 1
Silicon Genesis Corp 5 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Preferred Stock - Series 1-F *(1)(2)(4)
ACQUISITION DATE				Apr. 18, 2011
SHARES/PAR VALUE				912,453
COST BASIS				$ 456,389
VALUE				$ 70,806
Silicon Genesis Corp 6 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Preferred Stock - Series 1-G *(1)(2)(4)
ACQUISITION DATE				Mar. 10, 2016
SHARES/PAR VALUE				48,370,793
COST BASIS				$ 3,880,592
VALUE				$ 306,671
Silicon Genesis Corp 7 [Member]
Net Investment Income [Line Items]
TYPE OF INVESTMENT	[5],[6],[7],[8]			Preferred Stock - Series 1-H *(1)(2)(4)
ACQUISITION DATE				Mar. 10, 2016
SHARES/PAR VALUE				837,942
COST BASIS				$ 936,895
VALUE				35,529
Silicon Genesis Corp 8 [Member]
Net Investment Income [Line Items]
VALUE				$ 737,224
[1]Controlled investments.[2]Fair Value Level 3 security (108.7% of net assets).[3]Non-income producing security.[4]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At March 31, 2023, we held $28,125,998 (or 108.7% of net assets) in restricted securities (see Note 2).[5]Controlled investments.[6]Fair Value Level 3 security.[7]Non-income producing security.[8]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At December 31, 2022, we held $35,929,006 (or 117.3% of net assets) in restricted securities (see Note 2).[9]Security whose interest accrues until maturity however, based on March 31, 2023 valuation no such interest accrued during period ended March 31, 2023.[10]Security whose interest accrues over the life of the Note and is not payable until maturity. An interest adjustment was made during the year ending December 31, 2022 of approximately $21,400,000.[11]Affiliated issuer.[12]Affiliated issuer.[13]The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

THE COMPANY

THE COMPANY	3 Months Ended
	Mar. 31, 2023
Investment Company [Abstract]
THE COMPANY	NOTE 1. THE COMPANY Firsthand Technology Value Fund, Inc. (the “Company,” the “Fund,” “us,” “our,” and “we”), is a Maryland corporation and an externally managed, non-diversified, closed-end management investment company that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company acquired its initial portfolio of securities through the reorganization of Firsthand Technology Value Fund, a series of Firsthand Funds, into the Company. The reorganization was completed on April 15, 2011. The Company commenced operations on April 18th, 2011. Under normal circumstances, the Company will invest at least 80% of its assets for investment purposes in technology companies, which are considered to be those companies that derive at least 50% of their revenues from products and/ or services within the information technology sector or the “cleantech” sector. Information technology companies include, but are not limited to, those focused on computer hardware, software, telecommunications, networking, Internet, and consumer electronics. While there is no standard definition of cleantech, it is generally regarded as including goods and services designed to harness renewable energy and materials, eliminate emissions and waste, and reduce the use of natural resources. In addition, under normal circumstances we will invest at least 70% of our assets in privately held companies and in public companies with market capitalizations less than $250 million. Our portfolio is primarily composed of equity and equity derivative securities of technology and cleantech companies (as defined above). These investments generally range between $1 million and $10 million each, although the investment size will vary proportionately with the size of the Company’s capital base. The Company’s shares are listed on the NASDAQ Global Market under the symbol “SVVC.” Firsthand Capital Management, Inc., which was previously known as SiVest Group, Inc. (“FCM” or the “Advisor”), serves as the investment adviser to the Company. The Company is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946. CONSOLIDATION OF SUBSIDIARIES. During the fiscal years ended December 31, 2016 and 2017, with the approval of its Board of Directors, the Company organized three separate fully owned and controlled subsidiaries (as defined by the 1940 Act). Each subsidiary was a Cayman Islands corporation and the financial statements of each subsidiary were reported on a consolidated basis with the Company. Each subsidiary was formed for the purpose of holding one or more investments made by the Company, and was treated as a controlled foreign corporation under the Internal Revenue Code not separately subject to U.S. federal income tax. FVI was treated as the sole U.S. shareholder of each subsidiary. The Board of Directors of the Company approved the liquidation of those three Cayman subsidiaries on November 2, 2018. That liquidation was completed on December 27, 2018.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The following is a summary of significant accounting policies followed in the preparation of the Company’s financial statements included in this report: BASIS OF PRESENTATION Financial Services—Investment Companies Under the 1940 Act, ASC 946, and the regulations pursuant to Article 6 of Regulation S-X, we are precluded from consolidating any entity other than another investment company or an operating company which provides substantially all of its services to benefit us. Consequentially, as of December 31, 2018, the Company consolidated some special purpose entities. These special purpose entities only hold investments of the Company and have no other significant asset and liabilities. All significant intercompany transactions and balances have been eliminated in consolidation. USE OF ESTIMATES PORTFOLIO INVESTMENT VALUATIONS 28.1 CASH AND CASH EQUIVALENTS RESTRICTED SECURITIES 28,125,998 35,929,006 INCOME RECOGNITION SHARE VALUATION REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS INCOME TAXES FOREIGN CURRENCY TRANSLATION SECURITIES TRANSACTIONS CONCENTRATION OF CREDIT RISK OPTIONS Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. The average quarterly volume of the Company’s derivatives during the three months ended March 31, 2023 is as follows: Schedule of derivatives PURCHASED OPTIONS WARRANTS (NOTIONAL WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — 1,146,353 —

BUSINESS RISKS AND UNCERTAINTIE

BUSINESS RISKS AND UNCERTAINTIES	3 Months Ended
	Mar. 31, 2023
Business Risks And Uncertainties
BUSINESS RISKS AND UNCERTAINTIES	NOTE 3. BUSINESS RISKS AND UNCERTAINTIES We invest a substantial portion of our assets in privately-held companies, the securities of which are inherently illiquid. We also seek to invest in small publicly-traded companies that we believe have exceptional growth potential and to make opportunistic investments in publicly-traded companies, both large and small. In the case of investments in small publicly-traded companies, although these companies are publicly traded, their stock may not trade at high volumes, and prices can be volatile, which may restrict our ability to sell our positions. We may also be subject to contractual restrictions or securities law limits on our ability to sell portfolio holdings because of, for example, our affiliation with a portfolio company or the relative size of our holding in a company. These privately held and publicly traded businesses tend to lack management depth, have limited or no history of operations and typically have not attained profitability. Because of the speculative nature of our investments and the lack of public markets for privately held investments, there is greater risk of loss than is the case with traditional investment securities. We do not choose investments based on a strategy of diversification. We also do not rebalance the portfolio should one of our portfolio companies increase in value substantially relative to the rest of the portfolio. Therefore, the value of our portfolio may be more vulnerable to events affecting a single sector, industry or portfolio company and, therefore, may be subject to greater volatility than a company that follows a diversification strategy. Because there is typically no public or readily-ascertainable market for our interests in the small privately-held companies in which we invest, the valuation of those securities is determined in good faith by the Valuation Committee, comprised of all members of the Board who are not “interested persons” of the Company, as such term is defined in Section 2(a)(19) of the 1940 Act, in accordance with our Valuation Procedures and is subject to significant estimates and judgments. The determined value of the securities in our portfolio may differ significantly from the values that would be placed on these securities if a ready market for the securities existed. Any changes in valuation are recorded in our Statement of Operations as “Net increase (decrease) in unrealized appreciation on investments.” Changes in valuation of any of our investments in privately-held companies from one period to another may be volatile. The Board has engaged an independent valuation firm to provide it with valuation assistance with respect to certain of our portfolio investments. The Company intends to continue to engage an independent valuation firm to provide us with assistance regarding our determination of the fair value of select portfolio investments each quarter unless directed by the Board to cancel such valuation services. The scope of the services rendered by an independent valuation firm is at the discretion of the Board. The Board is ultimately and solely responsible for determining the fair value of the Company’s investments in good faith. With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process to be followed each quarter, as described below: (1) each quarter the valuation process begins with each portfolio company or investment being initially valued by the Advisor’s Valuation Committee or the independent valuation firm; (2) the Valuation Committee of the Board on a quarterly basis reviews the preliminary valuation of the Advisor’s Valuation Committee and that of the independent valuation firms and makes the fair value determination, in good faith, based on the valuation recommendations of the Advisor’s Valuation Committee and the independent valuation firms; and (3) at each quarterly Board meeting, the Board considers the valuations recommended by the Advisor’s Valuation Committee and the independent valuation firms that were previously submitted to the Valuation Committee of the Board and ratifies the fair value determinations made by the Valuation Committee of the Board.

INVESTMENT MANAGEMENT FEE

INVESTMENT MANAGEMENT FEE	3 Months Ended
	Mar. 31, 2023
Investment Management Fee
INVESTMENT MANAGEMENT FEE	NOTE 4. INVESTMENT MANAGEMENT FEE The Company has entered into an investment management agreement (the “Investment Management Agreement”) with FCM pursuant to which the Company will pay FCM a fee for providing investment management services consisting of two components—a base management fee and an incentive fee. The base management fee will be calculated at an annual rate of 2.00 The incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement, as of the termination date), commencing on April 15, 2011, and equals 20% of the Company’s realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fees, provided that the incentive fee determined as of December 31, 2022, will be calculated for a period of shorter than twelve calendar months to take into account any realized gains computed net of all realized capital losses and unrealized capital depreciation from inception. For the three months ended March 31, 2023, there were no

DEBT

DEBT	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
DEBT	NOTE 5. DEBT The Company currently has no plan to use leverage and does not have any significant outstanding debt obligations (other than normal operating expense accruals).

FAIR VALUE

FAIR VALUE	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE	NOTE 6. FAIR VALUE Securities traded on stock exchanges, or quoted by NASDAQ, are valued according to the NASDAQ Stock Market, Inc. (“NASDAQ”) official closing price, if applicable, or at their last reported sale price as of the close of trading on the New York Stock Exchange (“NYSE”) (normally 4:00 P.M. Eastern Time). If a security is not traded that day, the security will be valued at its most recent bid price. Securities traded in the over-the-counter market, but not quoted by NASDAQ, are valued at the last sale price (or, if the last sale price is not readily available, at the most recent closing bid price as quoted by brokers that make markets in the securities) at the close of trading on the NYSE. Securities traded both in the over-the-counter market and on a stock exchange are valued according to the broadest and most representative market. Securities and other assets that do not have market quotations readily available are valued at their fair value as determined by FCM, as the Board’s valuation designee under SEC rule 2a-5. Those valuations are determined in accordance with the Valuation Procedures used by FCM, subject to oversight by the Board. In pricing illiquid, privately placed securities, FCM, as the valuation designee, is responsible for (1) determining overall valuation guidelines and (2) ensuring that the investments of the Company are valued within the prescribed guidelines. FCM and the Board receive information and recommendations from an independent valuation firm. The values assigned to these investments are based on available information and do not necessarily represent amounts that might ultimately be realized when that investment is sold, as such amounts depend on future circumstances and cannot reasonably be determined until the individual investments are actually liquidated or become readily marketable. APPROACHES TO DETERMINING FAIR VALUE. GAAP. The main approaches to measuring fair value utilized are the market approach, the income approach, and the asset-based approach. The choice of which approach to use in a particular situation depends on the specific facts and circumstances associated with the company, as well as the purpose for which the valuation analysis is being conducted. Firsthand and the independent valuation firm rely primarily on the market approach. We also considered the income and asset-based approaches in our analysis because certain of the portfolio companies do not have substantial operating earnings relative to the value of their underlying assets. - Market Approach (M): The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. For example, the market approach often uses market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range each appropriate multiple falls requires the use of judgment in considering factors specific to the measurement (qualitative and quantitative). - Income Approach (I): The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) to a single present value amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. Those valuation techniques include present value techniques; option-pricing models, such as the Black-Scholes-Merton formula (a closed-form model) and a binomial model (a lattice model), which incorporate present value techniques; and the multi-period excess earnings method, which is used to measure the fair value of certain assets. - Asset-Based Approach (A): The asset-based approach examines the value of a company’s assets net of its liabilities to derive a value for the equity holders. FAIR VALUE MEASUREMENT. The guidance establishes three levels of the fair value hierarchy as follows: Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the date of measurement. Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument in an inactive market, prices for similar instruments in an active or inactive market, interest rates, prepayment speeds, credit risks, yield curves, default rates, and similar data. Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Company’s own assumptions about the assumptions a market participant would use in valuing the asset or liability based on the best information available. The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the inputs used to value the Company’s net assets as of March 31, 2022: Schedule of fair value of net asset ASSETS LEVEL 1 LEVEL 2 OTHER LEVEL 3 SIGNIFICANT Common Stocks Advanced Materials $ — $ — $ 202,672 Automotive — — 286 Equipment Leasing — — 3,210 Semiconductor Equipment 6,381,006 — — Total Common Stocks 6,381,006 — 206,168 Preferred Stocks Aerospace — — 699,713 Automotive — — 543,346 Equipment Leasing — — 488,901 Total Preferred Stocks — — 1,731,960 Asset Derivatives * Equity Contracts — — 1,714,038 Total Asset Derivatives — — 1,714,038 Convertible Notes Advanced Materials — — 100,000 Aerospace — — 6,559,791 Automotive — — 3,498,707 Medical Devices — — 14,315,334 Total Convertible Notes — — 24,473,832 Mutual Funds 854,831 — — Total $ 7,235,837 $ — $ 28,125,998 * Asset derivatives include warrants. At the end of each calendar quarter, management evaluates the Level 2 and Level 3 assets and liabilities for changes in liquidity, including but not limited to: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and Level 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges. Following is a reconciliation of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value. Schedule of unobservable inputs of fair value INVESTMENTS AT FAIR BALANCE NET NET SALES/ NET REALIZED NET UNREALIZED (1) TRANSFERS BALANCE Common Stocks Advanced Materials $ 337,500 $ — $ — $ — $ (134,828 ) $ — $ 202,672 Automotive 546 — — — (260 ) — 286 Equipment Leasing 11,130 — — — (7,920 ) — 3,210 Intellectual Property 111 — (7,966 ) (161,079 ) 168,934 — — Total Common Stocks 349,287 — (7,966 ) (161,079 ) 25,926 — 206,168 Preferred Stocks Aerospace 384,067 — — — 315,646 — 699,713 Automotive 1,049,478 — — — (506,132 ) — 543,346 Equipment Leasing 865,995 — — — (377,094 ) — 488,901 Intellectual Property 737,112 — (490,458 ) (7,697,239 ) 7,450,585 — — Total Preferred Stocks 3,036,652 — (490,458 ) (7,697,239 ) 6,883,005 — 1,731,960 Asset Derivatives Equity Contracts 957,125 — — (6,678 ) 763,591 — 1,714,038 Total Asset Derivatives 957,125 — — (6,678 ) 763,591 — 1,714,038 Convertible Notes Advanced Materials 100,000 — — — — — 100,000 Aerospace 6,559,791 — — — — — 6,559,791 Automotive 7,809,430 100,000 — — (4,410,723 ) — 3,498,707 Medical Devices 17,116,721 — — — (2,801,387 ) — 14,315,334 Total Convertible Notes 31,585,942 100,000 — — (7,212,110 ) — 24,473,832 Total $ 35,929,006 $ 100,000 $ (498,424 ) $ (7,864,996 ) $ 460,412 $ — $ 28,125,998 (1) The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of March 31, 2023 was $(7,165,783). The table below represents quantitative disclosure about significant unobservable inputs for Level 3 fair value measurements at March 31, 2023: Schedule of unobservable inputs fair value measurements FAIR VALUE VALUATION TECHNIQUES (1) UNOBSERVABLE INPUTS RANGE (1) Direct venture capital investments: Advanced Materials $ 0.3 Market Comparable Companies Option Pricing Model EBITDA Multiple (2) Revenue Multiple (2) Years to Maturity (2) Volatility (2) Risk-Free Rate (2) Discount for Lack of Marketability (3) 5.5x (5.5x) 0.7x – 1.0x (0.8x) 5 years (5 years) 50.0% (50.0%) 3.60% (3.60%) 22.7% (22.7%) Direct venture capital investments: Aerospace $ 9.0 Market Comparable Companies Option Pricing Model EBITDA Multiple (2) Years to Maturity (2) Volatility (2) Risk-Free Rate (2) 2.3x – 2.6x (2.3x) 5 years (5 years) 60.0% (60.0%) 3.60% (3.60%) Direct venture capital investments: Automotive $ 4.0 Prior Transaction Analysis Option Pricing Model Probability-Weighted Expected Return Method Years to Maturity (2) Volatility (2) Risk-Free Rate (2) Discount for Lack of Marketability (3) Going Concern Probability (2) 5 years (5 years) 50.0% (50.0%) 3.60% (3.60%) 0.0% - 22.7% (0.0%) 5% (5%) Direct venture capital investments: Equipment Leasing $ 0.5 Market Comparable Companies Liquidation Value Option Pricing Model EBITDA Multiple (2) Years to Maturity (2) Volatility (2) Risk-Free Rate (2) 2.9x – 4.1x (3.6x) 5 years (5 years) 50.0% (50.0%) 3.60% (3.60%) Direct venture capital investments: Medical Devices $ 14.3 Market Comparable Companies Revenue Multiple (2) 2.2x – 2.7x (2.5x) (1) Weighted average is calculated by weighting the significant unobservable input by the relative fair value of each investment in the category (2) An increase in the input would result in an increase in the security’s valuation; a decrease in the input would result in a decrease in the security’s valuation. (3) An increase in the input would result in a decrease in the security’s valuation; a decrease in the input would result in an increase in the security’s valuation. Changes in any of our unobservable inputs, individually, may change the fair value of certain of the Company’s investments. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of the Company’s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned.

FEDERAL INCOME TAXES

FEDERAL INCOME TAXES	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
FEDERAL INCOME TAXES	NOTE 7. FEDERAL INCOME TAXES Beginning in 2018, we were no longer able to qualify as a RIC under Subchapter M of the Code. The increase in value that resulted from the initial public offerings (IPOs) of Pivotal Systems and Revasum meant that we were no longer able to satisfy the diversification requirements for qualification as a RIC. As a result of this change, we were taxed as a corporation for our fiscal year ended December 31, 2018, and will continue to be taxed in that manner for future fiscal years, paying federal and applicable state corporate taxes on our taxable income, unless and until we are able to once again qualify as a RIC, based on changes in the composition of our portfolio. Consequently, at the close of each fiscal quarter beginning with the quarter ended June 30, 2018, we will record a deferred tax liability for any net realized gains and net ordinary income for the year-to-date period plus net unrealized gains as of the end of the quarter. The reorganization described in Note 1 (the formation of FVI as a fully owned subsidiary for investment activities) was structured to avoid any adverse tax consequences for the Company and its shareholders. For the fiscal years which the Company operates as a RIC, we believe Company’s engaging in investment activities through FVI did not, in our view, jeopardize the Company’s ability to continue to qualify as a RIC under the Code at that time when the Company was eligible to be treated as a RIC. The following information is based upon the U.S. federal income tax cost of portfolio investments as of March 31, 2023. Schedule of federal income tax cost of portfolio investments FEDERAL INCOME Gross unrealized appreciation $ 1,714,038 Gross unrealized depreciation (101,061,201 ) Net unrealized (depreciation) $ (99,347,163 ) Federal income tax cost, Investments $ 134,708,998 The Company did not qualify as a regulated investment company pursuant to Subchapter M of the Internal Revenue Code, therefore it is taxed as a corporation. As a corporation, the Company is obligated to pay federal and state income tax on taxable income. The Company’s net deferred tax asset balance has a full valuation allowance based on management’s estimate of future realization of such assets. The Company is currently using an estimated tax rate of 21 6.98 The Company’s income tax provision consists of the following as of December 31, 2022: Schedule of income tax provision Deferred tax (expense)/benefit Federal $ — State — Total deferred tax (expense)/benefit $ — Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Such temporary differences are principally: (i) taxes on unrealized gains/(losses), which are attributable to the temporary difference between fair market value and tax basis, and (ii) the net tax benefit of accumulated net operating losses and capital loss carryforwards. Deferred tax assets and liabilities are measured using effective tax rates expected to apply to taxable income in the years such temporary differences are realized or otherwise settled. Components of the Company’s deferred tax assets and liabilities as of December 31, 2022 are as follows: Schedule of deferred tax assets and liabilities AMOUNT Deferred tax assets: Net operating loss carryforward $ 4,616,720 Capital loss carryforward 6,960,412 Net unrealized losses (gains) on investment securities 28,726,530 Total deferred tax assets, net 40,303,662 Valuation allowance (40,303,662 ) Net $ — For the year ended December 31, 2022, the Company had an effective tax rate of 0 21 27.98 The effective tax rate and statutory federal income tax rate for the three-month periods ended March 31, 2023 and 2022 were as follows: Schedule of effective tax rate and statutory federal income tax rate THREE MONTHS ENDED THREE MONTHS ENDED Effective tax rate 0 0 Statutory federal income tax rate 21 21 The variance in the effective tax rate and statutory federal income tax rate for the three-month period ending March 31, 2023, is the result of changes to the deferred tax assets and related valuation allowance account. At March 31, 2023, the Company has established a full valuation allowance on its net deferred tax assets. To the extent the Company has a deferred tax asset or if a portion of the deferred tax liability is offset by a tax asset resulting from net operating losses, consideration is given to whether or not a valuation allowance is required against the deferred tax asset amount. A valuation allowance is required if, based on the evaluation criterion provided by Accounting Standard Codification (“ASC”) 740, Income Taxes (ASC 740), it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized. Among the factors considered in assessing the Company’s valuation allowance are: the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of the statutory carryforward periods, and the associated risks that operating and capital loss carryforwards may expire unused. Based on the Company’s assessment, it has determined that in the future it is more likely than not that the Company will not generate the necessary appropriate character of income within the carryforward periods to realize its deferred tax assets, and as such, has placed a full allowance on the deferred tax assets. From time to time, and as new information becomes available, the Company will modify its forecasts, estimates or assumptions regarding its deferred tax liability or asset. Modifications of the Company’s estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance, changes in generally accepted accounting principles or related guidance or interpretations thereof, limitations imposed on net operating losses (if any), and changes in applicable tax law could result in increases or decreases in the Company’s NAV, which could be material. Such changes could have a material impact on the Company’s NAV and results of operations with respect to the Company’s shareholders in the period it is recorded, even though the shareholders at such time might not have held shares in the Company at the time the deferred tax asset or liability had been established. The Company’s policy is to classify interest and penalties associated with underpayment of federal and state income taxes, if any, as income tax expense on its Statement of Operations. As of December 31, 2022, the Company did not have any interest or penalties associated with the underpayment of any income taxes. The Company files income tax returns in the U.S. federal jurisdiction and California. The Company has reviewed all major jurisdictions and concluded that there is no significant impact on the Company’s net assets and no tax liability resulting from unrecognized tax benefits relating to uncertain tax positions expected to be taken on its tax returns. Furthermore, management of the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months. As of December 31, 2022, the Company had net operating loss carryforwards for federal and state of income tax purposes of $ 16,500,072 As of December 31, 2022, the Company had net capital loss carryforwards for federal and state income tax purposes, which may be carried forward for 5 Schedule of net capital loss carryforwards EXPIRATION DATE AMOUNT 12/31/24 $ 14,230,073 12/31/25 7,516,642 12/31/27 3,129,665 Total $ 24,876,380

INVESTMENT TRANSACTIONS

INVESTMENT TRANSACTIONS	3 Months Ended
	Mar. 31, 2023
Investments, All Other Investments [Abstract]
INVESTMENT TRANSACTIONS	NOTE 8. INVESTMENT TRANSACTIONS Investment transactions (excluding short-term investments) were as follows for the quarter ended March 31, 2023. Schedule of investment transactions PURCHASES AND SALES Purchases of investment securities $ 0 Proceeds from sales and maturities of investment securities $ 498,424

SHARE BUYBACKS

SHARE BUYBACKS	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
SHARE BUYBACKS	NOTE 9. SHARE BUYBACKS SHARE BUYBACKS. 272,008 2 On November 10, 2017, the Board of Directors of the Fund approved a discretionary share purchase plan (the “Plan”). Pursuant to the Plan, the Fund was authorized to purchase in the open market up to $ 2 128,551 1.1 7,302,146 On August 31, 2018, the Fund announced a plan to repurchase up to $ 2 123,376 16.21 2.0 7,178,770 TENDER OFFERS. 20 23.2702 Of the 5,044,728 shares properly tendered, the Fund purchased 859,468 shares of common stock pursuant to the tender offer. On December 16, 2019, the Fund announced the commencement of a “modified Dutch auction” tender offer to purchase up to $ 2 February 14, 2020 285,714 7.00 6,893,056

INVESTMENTS IN AFFILIATES AND C

INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS	3 Months Ended
	Mar. 31, 2023
Investments in and Advances to Affiliates [Abstract]
INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS	NOTE 10. INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS Under the 1940 Act, the Company is required to identify investments where it owns greater than 5% (but less than 25%) of the portfolio company’s outstanding voting shares as an affiliate of the Company. Also, under the 1940 Act, the Company is required to identify investments where it owns greater than 25% of the portfolio company’s outstanding voting shares as a controlled investment of the Company. A summary of the Company’s investments in affiliates and controlled investments for the period from December 31, 2022, through March 31, 2023, is noted below: Schedule of investments in affiliates and controlled investments AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Equipment Leasing EQX Capital, Inc. Common Stock * $ 11,130 $ — $ — $ — $ — $ (7,920 ) $ 3,210 100,000 EQX Capital, Inc. Series A Preferred Stock * 865,995 — — — — (377,094 ) 488,901 1,950,000 Total Equipment Leasing $ 877,125 $ — $ — $ (385,014 ) $ 492,111 Aerospace Hera Systems, Inc. Convertible Note * 5,359,791 — 133,994 — — — 5,359,791 5,359,791 Hera Systems, Inc. Convertible Note * 1,200,000 — 14,989 — — — 1,200,000 1,200,000 Hera Systems, Inc. Series A Preferred * 4,735 — — — — 14,621 19,356 3,642,324 Hera Systems, Inc. Series B Preferred * 275,585 — — — — 218,694 494,279 7,039,203 Hera Systems, Inc. Series B Warrants * 478,608 — — — — 380,540 859,148 12,250,000 Hera Systems, Inc. Series B Warrants * 242,817 — — — — 193,064 435,881 6,214,922 Hera Systems, Inc. Series B Warrants * 205,118 — — — — 163,088 368,206 5,250,000 Hera Systems, Inc. Series B Warrants * 27,349 — — — — 21,745 49,094 700,000 Hera Systems, Inc. Series C Preferred * 103,747 — — — — 82,331 186,078 2,650,000 Total Aerospace $ 7,897,750 $ 148,983 $ — $ 1,074,083 $ 8,971,833 Medical Devices IntraOp Medical Corp. Convertible Note * 6,746,169 — — — — (1,104,103 ) 5,642,066 10,961,129 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 800,102 $ — $ — $ — $ — $ (130,948 ) $ 669,154 1,300,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 1,846,389 — — — — (302,187 ) 1,544,202 3,000,000 IntraOp Medical Corp. Convertible Note * 615,463 — — — — (100,729 ) 514,734 1,000,000 IntraOp Medical Corp. Convertible Note * 246,185 — — — — (40,291 ) 205,894 400,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 461,597 — — — — (75,547 ) 386,050 750,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 615,463 — — — — (100,729 ) 514,734 1,000,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 615,463 — — — — (100,729 ) 514,734 1,000,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 307,732 $ — $ — $ — $ — $ (50,365 ) $ 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 123,093 — — — — (20,146 ) 102,947 200,000 IntraOp Medical Corp. Convertible Note * 430,824 — — — — (70,510 ) 360,314 700,000 IntraOp Medical Corp. Convertible Note * 92,319 — — — — (15,109 ) 77,210 150,000 IntraOp Medical Corp. Convertible Note * 215,412 — — — — (35,255 ) 180,157 350,000 IntraOp Medical Corp. Series C Preferred * — — — — — — — 26,856,187 IntraOp Medical Corp. Term Note * 1,230,926 — — — — (201,458 ) 1,029,468 2,000,000 Total Medical Devices $ 17,116,721 $ — $ — $ (2,801,387 ) $ 14,315,334 Semiconductor Equipment Revasum, Inc. CDI * 3,520,496 — — — — 2,860,511 6,381,006 39,774,889 Total Semiconductor Equipment $ 3,520,496 $ — $ — $ 2,860,511 $ 6,381,006 Intellectual Property Silicon Genesis Corp. Common Stock * 111 — — (7,966 ) (161,080 ) 168,935 — — Silicon Genesis Corp. Common Warrants * 1 — — (1 ) (6,677 ) 6,677 — — Silicon Genesis Corp. Series 1-G Preferred * 306,671 — — (417,972 ) (3,462,620 ) 3,573,921 — — Silicon Genesis Corp. Series 1-H Preferred * 35,529 — — (7,241 ) (929,654 ) 901,366 — — AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Silicon Genesis Corp. Series 1-D Preferred * $ 2,552 $ — $ — $ (7,351 ) $ (424,549 ) $ 429,348 $ — — Silicon Genesis Corp. Series 1-E Preferred * 320,592 — — (49,292 ) (2,323,111 ) 2,051,811 — — Silicon Genesis Corp. Series 1-F Preferred * 70,806 — — (7,885 ) (448,504 ) 385,583 — — Silicon Genesis Corp. Series 1-C Preferred Stock * 962 — — (716 ) (108,802 ) 108,556 — — Total Intellectual Property $ 737,224 $ — $ (7,864,997 ) $ 7,626,197 $ — Advanced Materials UCT Coatings, Inc. Common Stock 337,500 — — — — (134,828 ) 202,672 1,500,000 Total Advanced Materials $ 337,500 $ — $ — $ (134,828 ) $ 202,672 Automotive Wrightspeed, Inc. Common Stock * 546 — — — — (260 ) 286 69,102 Wrightspeed, Inc. Convertible Note * 65,000 — — — — (36,000 ) 29,000 200,000 Wrightspeed, Inc. Convertible Note * 60,125 — — — — (33,300 ) 26,825 185,000 Wrightspeed, Inc. Convertible Note * 21,125 — — — — (11,700 ) 9,425 65,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 227,500 — — — — (126,000 ) 101,500 700,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 43,875 — — — — (24,300 ) 19,575 135,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note * $ 53,625 $ — $ — $ — $ — $ (29,700 ) $ 23,925 165,000 Wrightspeed, Inc. Convertible Note * 40,625 — — — — (22,500 ) 18,125 125,000 Wrightspeed, Inc. Convertible Note * — 100,000 — — — (85,500 ) 14,500 100,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,601,930 — — — — (887,223 ) 714,707 4,929,015 Wrightspeed, Inc. Convertible Note * 243,750 — — — — (135,000 ) 108,750 750,000 Wrightspeed, Inc. Convertible Note * 292,500 — — — — (162,000 ) 130,500 900,000 Wrightspeed, Inc. Convertible Note * 121,875 — — — — (67,500 ) 54,375 375,000 Wrightspeed, Inc. Convertible Note * 130,000 — — — — (72,000 ) 58,000 400,000 Wrightspeed, Inc. Convertible Note * 341,250 — — — — (189,000 ) 152,250 1,050,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 390,000 — — — — (216,000 ) 174,000 1,200,000 Wrightspeed, Inc. Convertible Note * 455,000 — — — — (252,000 ) 203,000 1,400,000 Wrightspeed, Inc. Convertible Note * 650,000 — — — — (360,000 ) 290,000 2,000,000 Wrightspeed, Inc. Convertible Note * 130,000 — — — — (72,000 ) 58,000 400,000 Wrightspeed, Inc. Convertible Note * 97,500 — — — — (54,000 ) 43,500 300,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Series AA Preferred * $ 1,049,478 $ — $ — $ — $ — $ (506,132 ) $ 543,346 60,733,693 Wrightspeed, Inc. Series AA Warrants * 3,232 — — — — (1,523 ) 1,709 609,756 Total Automotive $ 8,862,686 $ — $ — $ (4,918,638 ) $ 4,044,048 Total Affiliates and Controlled Investments $ 39,349,502 $ 148,983 $ (7,864,997 ) $ 3,320,924 $ 34,407,004 Total Affiliates 337,500 — — (134,828 ) 202,672 Total Controlled Investments $ 39,012,002 $ 148,983 $ (7,864,997 ) $ 3,455,752 $ 34,204,332 * Controlled Investments. (1) CDI: CHESS Depositary Interest As of March 31, 2023, Kevin Landis, the Company’s Chairman, President and Chief Executive Officer, represented the Company and sat on the boards of directors of Hera Systems, Inc.; IntraOp Medical Corp.; Revasum, Inc.; and Wrightspeed, Inc. Serving on boards of directors of portfolio companies may cause conflicts of interest. The Advisor has adopted various procedures to ensure that the Company will not be unfavorably affected by these potential conflicts.

MARKET DISRUPTION AND GEOPOLITI

MARKET DISRUPTION AND GEOPOLITICAL RISKS	3 Months Ended
	Mar. 31, 2023
Market Disruption And Geopolitical Risks
MARKET DISRUPTION AND GEOPOLITICAL RISKS	NOTE 11. MARKET DISRUPTION AND GEOPOLITICAL RISKS Certain local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, or other events could have a significant impact on a security or instrument. Since 2020, the novel strain of coronavirus (COVID-19) has negatively affected the worldwide economy, as well as the economies of individual countries, the financial health of individual companies and the market in general in significant and unforeseen ways. Following Russia’s large-scale invasion of Ukraine, the President of the United States signed an Executive Order in February 2022 prohibiting U.S. persons from entering transactions with the Central Bank of Russia and Executive Orders in March 2022 prohibiting U.S. persons from importing oil and gas from Russia as well as other popular Russian exports, such as diamonds, seafood and vodka. The duration of the coronavirus outbreak and the Russian-Ukraine conflict could adversely affect the Company’s performance. The ultimate impact of COVID-19 and Russia invasion on the financial performance of the Company’s investments is not reasonably estimable at this time.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12. SUBSEQUENT EVENTS Management has evaluated the impact of all subsequent events on the Company through the date the financial statements were issued and has determined that there were no subsequent events requiring recognition or disclosure in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Financial Services—Investment Companies Under the 1940 Act, ASC 946, and the regulations pursuant to Article 6 of Regulation S-X, we are precluded from consolidating any entity other than another investment company or an operating company which provides substantially all of its services to benefit us. Consequentially, as of December 31, 2018, the Company consolidated some special purpose entities. These special purpose entities only hold investments of the Company and have no other significant asset and liabilities. All significant intercompany transactions and balances have been eliminated in consolidation.
USE OF ESTIMATES	USE OF ESTIMATES
PORTFOLIO INVESTMENT VALUATIONS	PORTFOLIO INVESTMENT VALUATIONS 28.1
CASH AND CASH EQUIVALENTS	CASH AND CASH EQUIVALENTS
RESTRICTED SECURITIES	RESTRICTED SECURITIES 28,125,998 35,929,006
INCOME RECOGNITION	INCOME RECOGNITION
SHARE VALUATION	SHARE VALUATION
REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS	REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS
INCOME TAXES	INCOME TAXES
FOREIGN CURRENCY TRANSLATION	FOREIGN CURRENCY TRANSLATION
SECURITIES TRANSACTIONS	SECURITIES TRANSACTIONS
CONCENTRATION OF CREDIT RISK	CONCENTRATION OF CREDIT RISK
OPTIONS	OPTIONS Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. The average quarterly volume of the Company’s derivatives during the three months ended March 31, 2023 is as follows: Schedule of derivatives PURCHASED OPTIONS WARRANTS (NOTIONAL WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — 1,146,353 —

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Schedule of derivatives	Schedule of derivatives PURCHASED OPTIONS WARRANTS (NOTIONAL WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — 1,146,353 —

FAIR VALUE (Tables)

FAIR VALUE (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of fair value of net asset	Schedule of fair value of net asset ASSETS LEVEL 1 LEVEL 2 OTHER LEVEL 3 SIGNIFICANT Common Stocks Advanced Materials $ — $ — $ 202,672 Automotive — — 286 Equipment Leasing — — 3,210 Semiconductor Equipment 6,381,006 — — Total Common Stocks 6,381,006 — 206,168 Preferred Stocks Aerospace — — 699,713 Automotive — — 543,346 Equipment Leasing — — 488,901 Total Preferred Stocks — — 1,731,960 Asset Derivatives * Equity Contracts — — 1,714,038 Total Asset Derivatives — — 1,714,038 Convertible Notes Advanced Materials — — 100,000 Aerospace — — 6,559,791 Automotive — — 3,498,707 Medical Devices — — 14,315,334 Total Convertible Notes — — 24,473,832 Mutual Funds 854,831 — — Total $ 7,235,837 $ — $ 28,125,998 * Asset derivatives include warrants.
Schedule of unobservable inputs of fair value	Schedule of unobservable inputs of fair value INVESTMENTS AT FAIR BALANCE NET NET SALES/ NET REALIZED NET UNREALIZED (1) TRANSFERS BALANCE Common Stocks Advanced Materials $ 337,500 $ — $ — $ — $ (134,828 ) $ — $ 202,672 Automotive 546 — — — (260 ) — 286 Equipment Leasing 11,130 — — — (7,920 ) — 3,210 Intellectual Property 111 — (7,966 ) (161,079 ) 168,934 — — Total Common Stocks 349,287 — (7,966 ) (161,079 ) 25,926 — 206,168 Preferred Stocks Aerospace 384,067 — — — 315,646 — 699,713 Automotive 1,049,478 — — — (506,132 ) — 543,346 Equipment Leasing 865,995 — — — (377,094 ) — 488,901 Intellectual Property 737,112 — (490,458 ) (7,697,239 ) 7,450,585 — — Total Preferred Stocks 3,036,652 — (490,458 ) (7,697,239 ) 6,883,005 — 1,731,960 Asset Derivatives Equity Contracts 957,125 — — (6,678 ) 763,591 — 1,714,038 Total Asset Derivatives 957,125 — — (6,678 ) 763,591 — 1,714,038 Convertible Notes Advanced Materials 100,000 — — — — — 100,000 Aerospace 6,559,791 — — — — — 6,559,791 Automotive 7,809,430 100,000 — — (4,410,723 ) — 3,498,707 Medical Devices 17,116,721 — — — (2,801,387 ) — 14,315,334 Total Convertible Notes 31,585,942 100,000 — — (7,212,110 ) — 24,473,832 Total $ 35,929,006 $ 100,000 $ (498,424 ) $ (7,864,996 ) $ 460,412 $ — $ 28,125,998 (1) The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of March 31, 2023 was $(7,165,783).
Schedule of unobservable inputs fair value measurements	Schedule of unobservable inputs fair value measurements FAIR VALUE VALUATION TECHNIQUES (1) UNOBSERVABLE INPUTS RANGE (1) Direct venture capital investments: Advanced Materials $ 0.3 Market Comparable Companies Option Pricing Model EBITDA Multiple (2) Revenue Multiple (2) Years to Maturity (2) Volatility (2) Risk-Free Rate (2) Discount for Lack of Marketability (3) 5.5x (5.5x) 0.7x – 1.0x (0.8x) 5 years (5 years) 50.0% (50.0%) 3.60% (3.60%) 22.7% (22.7%) Direct venture capital investments: Aerospace $ 9.0 Market Comparable Companies Option Pricing Model EBITDA Multiple (2) Years to Maturity (2) Volatility (2) Risk-Free Rate (2) 2.3x – 2.6x (2.3x) 5 years (5 years) 60.0% (60.0%) 3.60% (3.60%) Direct venture capital investments: Automotive $ 4.0 Prior Transaction Analysis Option Pricing Model Probability-Weighted Expected Return Method Years to Maturity (2) Volatility (2) Risk-Free Rate (2) Discount for Lack of Marketability (3) Going Concern Probability (2) 5 years (5 years) 50.0% (50.0%) 3.60% (3.60%) 0.0% - 22.7% (0.0%) 5% (5%) Direct venture capital investments: Equipment Leasing $ 0.5 Market Comparable Companies Liquidation Value Option Pricing Model EBITDA Multiple (2) Years to Maturity (2) Volatility (2) Risk-Free Rate (2) 2.9x – 4.1x (3.6x) 5 years (5 years) 50.0% (50.0%) 3.60% (3.60%) Direct venture capital investments: Medical Devices $ 14.3 Market Comparable Companies Revenue Multiple (2) 2.2x – 2.7x (2.5x) (1) Weighted average is calculated by weighting the significant unobservable input by the relative fair value of each investment in the category (2) An increase in the input would result in an increase in the security’s valuation; a decrease in the input would result in a decrease in the security’s valuation. (3) An increase in the input would result in a decrease in the security’s valuation; a decrease in the input would result in an increase in the security’s valuation.

FEDERAL INCOME TAXES (Tables)

FEDERAL INCOME TAXES (Tables)	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of federal income tax cost of portfolio investments	Schedule of federal income tax cost of portfolio investments FEDERAL INCOME Gross unrealized appreciation $ 1,714,038 Gross unrealized depreciation (101,061,201 ) Net unrealized (depreciation) $ (99,347,163 ) Federal income tax cost, Investments $ 134,708,998
Schedule of income tax provision	Schedule of income tax provision Deferred tax (expense)/benefit Federal $ — State — Total deferred tax (expense)/benefit $ —
Schedule of deferred tax assets and liabilities	Schedule of deferred tax assets and liabilities AMOUNT Deferred tax assets: Net operating loss carryforward $ 4,616,720 Capital loss carryforward 6,960,412 Net unrealized losses (gains) on investment securities 28,726,530 Total deferred tax assets, net 40,303,662 Valuation allowance (40,303,662 ) Net $ —
Schedule of effective tax rate and statutory federal income tax rate	Schedule of effective tax rate and statutory federal income tax rate THREE MONTHS ENDED THREE MONTHS ENDED Effective tax rate 0 0 Statutory federal income tax rate 21 21
Schedule of net capital loss carryforwards	Schedule of net capital loss carryforwards EXPIRATION DATE AMOUNT 12/31/24 $ 14,230,073 12/31/25 7,516,642 12/31/27 3,129,665 Total $ 24,876,380

INVESTMENT TRANSACTIONS (Tables

INVESTMENT TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, All Other Investments [Abstract]
Schedule of investment transactions	Schedule of investment transactions PURCHASES AND SALES Purchases of investment securities $ 0 Proceeds from sales and maturities of investment securities $ 498,424

INVESTMENTS IN AFFILIATES AND_2

INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2023
Investments in and Advances to Affiliates [Abstract]
Schedule of investments in affiliates and controlled investments	Schedule of investments in affiliates and controlled investments AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Equipment Leasing EQX Capital, Inc. Common Stock * $ 11,130 $ — $ — $ — $ — $ (7,920 ) $ 3,210 100,000 EQX Capital, Inc. Series A Preferred Stock * 865,995 — — — — (377,094 ) 488,901 1,950,000 Total Equipment Leasing $ 877,125 $ — $ — $ (385,014 ) $ 492,111 Aerospace Hera Systems, Inc. Convertible Note * 5,359,791 — 133,994 — — — 5,359,791 5,359,791 Hera Systems, Inc. Convertible Note * 1,200,000 — 14,989 — — — 1,200,000 1,200,000 Hera Systems, Inc. Series A Preferred * 4,735 — — — — 14,621 19,356 3,642,324 Hera Systems, Inc. Series B Preferred * 275,585 — — — — 218,694 494,279 7,039,203 Hera Systems, Inc. Series B Warrants * 478,608 — — — — 380,540 859,148 12,250,000 Hera Systems, Inc. Series B Warrants * 242,817 — — — — 193,064 435,881 6,214,922 Hera Systems, Inc. Series B Warrants * 205,118 — — — — 163,088 368,206 5,250,000 Hera Systems, Inc. Series B Warrants * 27,349 — — — — 21,745 49,094 700,000 Hera Systems, Inc. Series C Preferred * 103,747 — — — — 82,331 186,078 2,650,000 Total Aerospace $ 7,897,750 $ 148,983 $ — $ 1,074,083 $ 8,971,833 Medical Devices IntraOp Medical Corp. Convertible Note * 6,746,169 — — — — (1,104,103 ) 5,642,066 10,961,129 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 800,102 $ — $ — $ — $ — $ (130,948 ) $ 669,154 1,300,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 1,846,389 — — — — (302,187 ) 1,544,202 3,000,000 IntraOp Medical Corp. Convertible Note * 615,463 — — — — (100,729 ) 514,734 1,000,000 IntraOp Medical Corp. Convertible Note * 246,185 — — — — (40,291 ) 205,894 400,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 461,597 — — — — (75,547 ) 386,050 750,000 IntraOp Medical Corp. Convertible Note * 307,731 — — — — (50,364 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 615,463 — — — — (100,729 ) 514,734 1,000,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 615,463 — — — — (100,729 ) 514,734 1,000,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 307,732 $ — $ — $ — $ — $ (50,365 ) $ 257,367 500,000 IntraOp Medical Corp. Convertible Note * 307,732 — — — — (50,365 ) 257,367 500,000 IntraOp Medical Corp. Convertible Note * 123,093 — — — — (20,146 ) 102,947 200,000 IntraOp Medical Corp. Convertible Note * 430,824 — — — — (70,510 ) 360,314 700,000 IntraOp Medical Corp. Convertible Note * 92,319 — — — — (15,109 ) 77,210 150,000 IntraOp Medical Corp. Convertible Note * 215,412 — — — — (35,255 ) 180,157 350,000 IntraOp Medical Corp. Series C Preferred * — — — — — — — 26,856,187 IntraOp Medical Corp. Term Note * 1,230,926 — — — — (201,458 ) 1,029,468 2,000,000 Total Medical Devices $ 17,116,721 $ — $ — $ (2,801,387 ) $ 14,315,334 Semiconductor Equipment Revasum, Inc. CDI * 3,520,496 — — — — 2,860,511 6,381,006 39,774,889 Total Semiconductor Equipment $ 3,520,496 $ — $ — $ 2,860,511 $ 6,381,006 Intellectual Property Silicon Genesis Corp. Common Stock * 111 — — (7,966 ) (161,080 ) 168,935 — — Silicon Genesis Corp. Common Warrants * 1 — — (1 ) (6,677 ) 6,677 — — Silicon Genesis Corp. Series 1-G Preferred * 306,671 — — (417,972 ) (3,462,620 ) 3,573,921 — — Silicon Genesis Corp. Series 1-H Preferred * 35,529 — — (7,241 ) (929,654 ) 901,366 — — AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Silicon Genesis Corp. Series 1-D Preferred * $ 2,552 $ — $ — $ (7,351 ) $ (424,549 ) $ 429,348 $ — — Silicon Genesis Corp. Series 1-E Preferred * 320,592 — — (49,292 ) (2,323,111 ) 2,051,811 — — Silicon Genesis Corp. Series 1-F Preferred * 70,806 — — (7,885 ) (448,504 ) 385,583 — — Silicon Genesis Corp. Series 1-C Preferred Stock * 962 — — (716 ) (108,802 ) 108,556 — — Total Intellectual Property $ 737,224 $ — $ (7,864,997 ) $ 7,626,197 $ — Advanced Materials UCT Coatings, Inc. Common Stock 337,500 — — — — (134,828 ) 202,672 1,500,000 Total Advanced Materials $ 337,500 $ — $ — $ (134,828 ) $ 202,672 Automotive Wrightspeed, Inc. Common Stock * 546 — — — — (260 ) 286 69,102 Wrightspeed, Inc. Convertible Note * 65,000 — — — — (36,000 ) 29,000 200,000 Wrightspeed, Inc. Convertible Note * 60,125 — — — — (33,300 ) 26,825 185,000 Wrightspeed, Inc. Convertible Note * 21,125 — — — — (11,700 ) 9,425 65,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 227,500 — — — — (126,000 ) 101,500 700,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 43,875 — — — — (24,300 ) 19,575 135,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note * $ 53,625 $ — $ — $ — $ — $ (29,700 ) $ 23,925 165,000 Wrightspeed, Inc. Convertible Note * 40,625 — — — — (22,500 ) 18,125 125,000 Wrightspeed, Inc. Convertible Note * — 100,000 — — — (85,500 ) 14,500 100,000 Wrightspeed, Inc. Convertible Note * 81,250 — — — — (45,000 ) 36,250 250,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,601,930 — — — — (887,223 ) 714,707 4,929,015 Wrightspeed, Inc. Convertible Note * 243,750 — — — — (135,000 ) 108,750 750,000 Wrightspeed, Inc. Convertible Note * 292,500 — — — — (162,000 ) 130,500 900,000 Wrightspeed, Inc. Convertible Note * 121,875 — — — — (67,500 ) 54,375 375,000 Wrightspeed, Inc. Convertible Note * 130,000 — — — — (72,000 ) 58,000 400,000 Wrightspeed, Inc. Convertible Note * 341,250 — — — — (189,000 ) 152,250 1,050,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 Wrightspeed, Inc. Convertible Note * 390,000 — — — — (216,000 ) 174,000 1,200,000 Wrightspeed, Inc. Convertible Note * 455,000 — — — — (252,000 ) 203,000 1,400,000 Wrightspeed, Inc. Convertible Note * 650,000 — — — — (360,000 ) 290,000 2,000,000 Wrightspeed, Inc. Convertible Note * 130,000 — — — — (72,000 ) 58,000 400,000 Wrightspeed, Inc. Convertible Note * 97,500 — — — — (54,000 ) 43,500 300,000 Wrightspeed, Inc. Convertible Note * 325,000 — — — — (180,000 ) 145,000 1,000,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Series AA Preferred * $ 1,049,478 $ — $ — $ — $ — $ (506,132 ) $ 543,346 60,733,693 Wrightspeed, Inc. Series AA Warrants * 3,232 — — — — (1,523 ) 1,709 609,756 Total Automotive $ 8,862,686 $ — $ — $ (4,918,638 ) $ 4,044,048 Total Affiliates and Controlled Investments $ 39,349,502 $ 148,983 $ (7,864,997 ) $ 3,320,924 $ 34,407,004 Total Affiliates 337,500 — — (134,828 ) 202,672 Total Controlled Investments $ 39,012,002 $ 148,983 $ (7,864,997 ) $ 3,455,752 $ 34,204,332 * Controlled Investments. (1) CDI: CHESS Depositary Interest As of March 31, 2023, Kevin Landis, the Company’s Chairman, President and Chief Executive Officer, represented the Company and sat on the boards of directors of Hera Systems, Inc.; IntraOp Medical Corp.; Revasum, Inc.; and Wrightspeed, Inc. Serving on boards of directors of portfolio companies may cause conflicts of interest. The Advisor has adopted various procedures to ensure that the Company will not be unfavorably affected by these potential conflicts.

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Accounting Policies [Abstract]
PURCHASED OPTIONS (CONTRACTS)	$ 0
WARRANTS (NOTIONAL VALUE)	1,146,353
WRITTEN OPTIONS (CONTRACTS)	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Venture capital investments	$ 28,100,000
Restricted securities	$ 28,125,998	$ 35,929,006

INVESTMENT MANAGEMENT FEE (Deta

INVESTMENT MANAGEMENT FEE (Details Narrative)	3 Months Ended
	Mar. 31, 2023 USD ($)
Investment Management Fee
Annual rate	2%
Incentive fee adjustments	$ 0

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($)		Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		$ 35,620,583	$ 40,203,857
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		7,235,837
Fair Value, Inputs, Level 1 [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Mutual Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		854,831
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		6,381,006
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Equity Contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	[1]	0
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Asset Derivatives [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	[1]	0
Fair Value, Inputs, Level 1 [Member] | Advanced Materials [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Advanced Materials [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Automotive [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Automotive [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Automotive [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Equipment Leasing [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Equipment Leasing [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Semiconductor Equipment [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		6,381,006
Fair Value, Inputs, Level 1 [Member] | Aerospace [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Aerospace [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 1 [Member] | Medical Devices [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Mutual Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Equity Contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	[1]	0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Asset Derivatives [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	[1]	0
Fair Value, Inputs, Level 2 [Member] | Advanced Materials [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Advanced Materials [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Automotive [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Automotive [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Automotive [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Equipment Leasing [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Equipment Leasing [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Semiconductor Equipment [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Aerospace [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Aerospace [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 2 [Member] | Medical Devices [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		28,125,998
Fair Value, Inputs, Level 3 [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		24,473,832
Fair Value, Inputs, Level 3 [Member] | Mutual Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		206,168
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		1,731,960
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Equity Contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	[1]	1,714,038
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Asset Derivatives [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	[1]	1,714,038
Fair Value, Inputs, Level 3 [Member] | Advanced Materials [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		100,000
Fair Value, Inputs, Level 3 [Member] | Advanced Materials [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		202,672
Fair Value, Inputs, Level 3 [Member] | Automotive [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		3,498,707
Fair Value, Inputs, Level 3 [Member] | Automotive [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		286
Fair Value, Inputs, Level 3 [Member] | Automotive [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		543,346
Fair Value, Inputs, Level 3 [Member] | Equipment Leasing [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		3,210
Fair Value, Inputs, Level 3 [Member] | Equipment Leasing [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		488,901
Fair Value, Inputs, Level 3 [Member] | Semiconductor Equipment [Member] | Common Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		0
Fair Value, Inputs, Level 3 [Member] | Aerospace [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		6,559,791
Fair Value, Inputs, Level 3 [Member] | Aerospace [Member] | Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		699,713
Fair Value, Inputs, Level 3 [Member] | Medical Devices [Member] | Convertible Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets		$ 14,315,334
[1]Asset derivatives include warrants.

FAIR VALUE (Details 1)

FAIR VALUE (Details 1)	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	$ 35,929,006
NET PURCHASES/CONVERSIONS	100,000
NET SALES/CONVERSIONS	(498,424)
NET REALIZED GAINS/(LOSSES)	(7,864,996)
NET UNREALIZED APPRECIATION (DEPRECIATION)	460,412	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	28,125,998
Convertible Notes [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	31,585,942
NET PURCHASES/CONVERSIONS	100,000
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(7,212,110)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	24,473,832
Common Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	349,287
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	(7,966)
NET REALIZED GAINS/(LOSSES)	(161,079)
NET UNREALIZED APPRECIATION (DEPRECIATION)	25,926	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	206,168
Common Stock [Member] | Intellectual Property [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	111
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	(7,966)
NET REALIZED GAINS/(LOSSES)	(161,079)
NET UNREALIZED APPRECIATION (DEPRECIATION)	168,934	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	0
Preferred Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	3,036,652
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	(490,458)
NET REALIZED GAINS/(LOSSES)	(7,697,239)
NET UNREALIZED APPRECIATION (DEPRECIATION)	6,883,005	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	1,731,960
Preferred Stock [Member] | Equity Contracts [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	957,125
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	(6,678)
NET UNREALIZED APPRECIATION (DEPRECIATION)	763,591	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	1,714,038
Preferred Stock [Member] | Asset Derivatives [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	957,125
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	(6,678)
NET UNREALIZED APPRECIATION (DEPRECIATION)	763,591	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	1,714,038
Preferred Stock [Member] | Intellectual Property [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	737,112
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	(490,458)
NET REALIZED GAINS/(LOSSES)	(7,697,239)
NET UNREALIZED APPRECIATION (DEPRECIATION)	7,450,585	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	0
Advanced Materials [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	337,500
ENDING BALANCE	202,672
Advanced Materials [Member] | Convertible Notes [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	100,000
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	0	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	100,000
Advanced Materials [Member] | Common Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	337,500
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(134,828)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	202,672
Automotive [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	8,862,686
ENDING BALANCE	4,044,048
Automotive [Member] | Convertible Notes [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	7,809,430
NET PURCHASES/CONVERSIONS	100,000
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(4,410,723)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	3,498,707
Automotive [Member] | Common Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	546
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(260)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	286
Automotive [Member] | Preferred Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	1,049,478
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(506,132)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	543,346
Equipment Leasing [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	877,125
ENDING BALANCE	492,111
Equipment Leasing [Member] | Common Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	11,130
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(7,920)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	3,210
Equipment Leasing [Member] | Preferred Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	865,995
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(377,094)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	488,901
Aerospace [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	7,897,750
ENDING BALANCE	8,971,833
Aerospace [Member] | Convertible Notes [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	6,559,791
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	0	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	6,559,791
Aerospace [Member] | Preferred Stock [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	384,067
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	315,646	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	699,713
Medical Devices [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	17,116,721
ENDING BALANCE	14,315,334
Medical Devices [Member] | Convertible Notes [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
BEGINNING BALANCE	17,116,721
NET PURCHASES/CONVERSIONS	0
NET SALES/CONVERSIONS	0
NET REALIZED GAINS/(LOSSES)	0
NET UNREALIZED APPRECIATION (DEPRECIATION)	(2,801,387)	[1]
TRANSFERS IN (OUT) OF LEVEL 3	0
ENDING BALANCE	$ 14,315,334
[1]The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of March 31, 2023 was $(7,165,783).

FAIR VALUE (Details 2)

FAIR VALUE (Details 2) $ in Millions	Mar. 31, 2023 USD ($)
Advanced Materials [Member]
Property, Plant and Equipment [Line Items]
FAIR VALUE	$ 0.3
Aerospace [Member]
Property, Plant and Equipment [Line Items]
FAIR VALUE	9
Automotive [Member]
Property, Plant and Equipment [Line Items]
FAIR VALUE	4
Equipment Leasing [Member]
Property, Plant and Equipment [Line Items]
FAIR VALUE	0.5
Medical Devices [Member]
Property, Plant and Equipment [Line Items]
FAIR VALUE	$ 14.3

FEDERAL INCOME TAXES (Details)

FEDERAL INCOME TAXES (Details)	Mar. 31, 2023 USD ($)
Income Tax Disclosure [Abstract]
Gross unrealized appreciation	$ 1,714,038
Gross unrealized depreciation	(101,061,201)
Net unrealized (depreciation)	(99,347,163)
Federal income tax cost, Investments	$ 134,708,998

FEDERAL INCOME TAXES (Details 1

FEDERAL INCOME TAXES (Details 1)	3 Months Ended
	Mar. 31, 2023 USD ($)
Income Tax Disclosure [Abstract]
Federal	$ 0
State	0
Total deferred tax (expense)/benefit	$ 0

FEDERAL INCOME TAXES (Details 2

FEDERAL INCOME TAXES (Details 2)	Mar. 31, 2023 USD ($)
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 4,616,720
Capital loss carryforward	6,960,412
Net unrealized losses (gains) on investment securities	28,726,530
Total deferred tax assets	40,303,662
Valuation allowance	(40,303,662)
Net	$ 0

FEDERAL INCOME TAXES (Details 3

FEDERAL INCOME TAXES (Details 3)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	0%	0%
Statutory federal income tax rate	21%	21%	27.98%

FEDERAL INCOME TAXES (Details 4

FEDERAL INCOME TAXES (Details 4)	3 Months Ended
	Mar. 31, 2023 USD ($)
Tax Credit Carryforward [Line Items]
Capital loss carryforwards	$ 6,960,412
Capital Loss Carryforward 1 [Member]
Tax Credit Carryforward [Line Items]
EXPIRATION DATE	12/31/24
Capital loss carryforwards	$ 14,230,073
Capital Loss Carryforward 2 [Member]
Tax Credit Carryforward [Line Items]
EXPIRATION DATE	12/31/25
Capital loss carryforwards	$ 7,516,642
Capital Loss Carryforward 3 [Member]
Tax Credit Carryforward [Line Items]
EXPIRATION DATE	12/31/27
Capital loss carryforwards	$ 3,129,665
Capital Loss Carryforward [Member]
Tax Credit Carryforward [Line Items]
Capital loss carryforwards	$ 24,876,380

FEDERAL INCOME TAXES (Details N

FEDERAL INCOME TAXES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Statutory tax rate	21%
State tax rate	6.98%
Effective tax rate			0%
State income tax	21%	21%	27.98%
Net operating loss carryforwards			$ 16,500,072
Net capital loss carryforwards			5 years

INVESTMENT TRANSACTIONS (Detail

INVESTMENT TRANSACTIONS (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Investments, All Other Investments [Abstract]
Purchases of investment securities	$ 0
Proceeds from sales and maturities of investment securities	$ 498,424

SHARE BUYBACKS (Details Narrati

SHARE BUYBACKS (Details Narrative) - USD ($)

1 Months Ended

Nov. 10, 2017

Dec. 16, 2019

Aug. 31, 2018

Apr. 26, 2016

Dec. 22, 2014

Mar. 31, 2023

Dec. 31, 2022

Mar. 31, 2022

Dec. 31, 2021

Mar. 31, 2020

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2014

Accumulated Other Comprehensive Income (Loss) [Line Items]

Repurchased of shares

272,008

Repurchased of shares value

$ 123,376

$ 2,000,000

Authorized to purchase

$ 2,000,000

Repurchased and retired shares

128,551

Repurchased and retired shares value

$ 1,100,000

Shares outstanding

6,893,056

6,893,056

6,893,056

6,893,056

6,893,056

7,178,770

7,302,146

Average price

$ 16.21

Common shares for cash

$ 20,000,000

Trading price

$ 23.2702

Tender offer description

Of the 5,044,728 shares properly tendered, the Fund purchased 859,468 shares of common stock pursuant to the tender offer.

Tender offer

$ 2,000,000

Tender offer expired

Feb. 14, 2020

Purchase of shares

285,714

Common stock price

$ 7

S V V C Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Repurchased of shares value

$ 2,000,000

Total consideration amount

$ 2,000,000

INVESTMENTS IN AFFILIATES AND_3

INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) shares
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 35,929,006
ENDING BALANCE	28,125,998
Equipment Leasing [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	877,125
INTEREST	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	(385,014)
ENDING BALANCE	492,111
Aerospace [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	7,897,750
INTEREST	148,983
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	1,074,083
ENDING BALANCE	8,971,833
Medical Devices [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	17,116,721
INTEREST	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	(2,801,387)
ENDING BALANCE	14,315,334
Semiconductor Equipment [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	3,520,496
INTEREST	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	2,860,511
ENDING BALANCE	6,381,006
Intellectuals Property [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	737,224
INTEREST	0
REALIZED GAIN (LOSS)	(7,864,997)
CHANGE IN APPRECIATION/(DEPRECIATION)	7,626,197
ENDING BALANCE	0
Advanced Materials [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	337,500
INTEREST	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	(134,828)
ENDING BALANCE	202,672
Automotive [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	8,862,686
INTEREST	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	(4,918,638)
ENDING BALANCE	4,044,048
E Q X Capital Inc Common Stock [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	11,130	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(7,920)	[1]
ENDING BALANCE	$ 3,210	[1]
SHARES HELD | shares	100,000	[1]
E Q X Capital Inc Series A Preferred Stock [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 865,995	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(377,094)	[1]
ENDING BALANCE	$ 488,901	[1]
SHARES HELD | shares	1,950,000	[1]
Hera Systems Inc Convertible Note [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 5,359,791	[1]
PURCHASE/MERGER	0	[1]
INTEREST	133,994	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	0	[1]
ENDING BALANCE	$ 5,359,791	[1]
SHARES HELD | shares	5,359,791	[1]
Hera Systems Inc Convertible Note 1 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 1,200,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	14,989	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	0	[1]
ENDING BALANCE	$ 1,200,000	[1]
SHARES HELD | shares	1,200,000	[1]
Hera Systems Inc Series A Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 4,735	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	14,621	[1]
ENDING BALANCE	$ 19,356	[1]
SHARES HELD | shares	3,642,324	[1]
Hera Systems Inc Series B Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 275,585	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	218,694	[1]
ENDING BALANCE	$ 494,279	[1]
SHARES HELD | shares	7,039,203
Hera Systems Inc Series B Warrants [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 478,608
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	380,540	[1]
ENDING BALANCE	$ 859,148	[1]
SHARES HELD | shares	12,250,000	[1]
Hera Systems Inc Series B Warrants 1 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 242,817	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	193,064	[1]
ENDING BALANCE	$ 435,881	[1]
SHARES HELD | shares	6,214,922	[1]
Hera Systems Inc Series B Warrants 2 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 205,118	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	163,088	[1]
ENDING BALANCE	$ 368,206	[1]
SHARES HELD | shares	5,250,000	[1]
Hera Systems Inc Series B Warrants 3 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 27,349	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	21,745	[1]
ENDING BALANCE	$ 49,094	[1]
SHARES HELD | shares	700,000	[1]
Hera Systems Inc Series C Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 103,747	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	82,331	[1]
ENDING BALANCE	$ 186,078	[1]
SHARES HELD | shares	2,650,000	[1]
Intra Op Medical Corp Convertible Note [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 6,746,169	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(1,104,103)	[1]
ENDING BALANCE	$ 5,642,066	[1]
SHARES HELD | shares	10,961,129	[1]
Intra Op Medical Corp Convertible Note 1 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 800,102	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(130,948)	[1]
ENDING BALANCE	$ 669,154	[1]
SHARES HELD | shares	1,300,000	[1]
Intra Op Medical Corp Convertible Note 2 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,731	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,364)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 3 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,731	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,364)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 4 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 1,846,389	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(302,187)	[1]
ENDING BALANCE	$ 1,544,202	[1]
SHARES HELD | shares	3,000,000	[1]
Intra Op Medical Corp Convertible Note 5 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 615,463	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(100,729)	[1]
ENDING BALANCE	$ 514,734	[1]
SHARES HELD | shares	1,000,000	[1]
Intra Op Medical Corp Convertible Note 6 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 246,185	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(40,291)	[1]
ENDING BALANCE	$ 205,894	[1]
SHARES HELD | shares	400,000	[1]
Intra Op Medical Corp Convertible Note 7 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,731	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,364)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 8 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 461,597	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(75,547)	[1]
ENDING BALANCE	$ 386,050	[1]
SHARES HELD | shares	750,000	[1]
Intra Op Medical Corp Convertible Note 9 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,731	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,364)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 10 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,732	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,365)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 11 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,732	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,365)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 12 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 615,463	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(100,729)	[1]
ENDING BALANCE	$ 514,734	[1]
SHARES HELD | shares	1,000,000	[1]
Intra Op Medical Corp Convertible Note 13 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,732	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,365)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 14 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 615,463	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(100,729)	[1]
ENDING BALANCE	$ 514,734	[1]
SHARES HELD | shares	1,000,000	[1]
Intra Op Medical Corp Convertible Note 15 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,732	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,365)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 16 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,732	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,365)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 17 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 307,732	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(50,365)	[1]
ENDING BALANCE	$ 257,367	[1]
SHARES HELD | shares	500,000	[1]
Intra Op Medical Corp Convertible Note 18 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 123,093	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(20,146)	[1]
ENDING BALANCE	$ 102,947	[1]
SHARES HELD | shares	200,000	[1]
Intra Op Medical Corp Convertible Note 19 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 430,824	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(70,510)	[1]
ENDING BALANCE	$ 360,314	[1]
SHARES HELD | shares	700,000	[1]
Intra Op Medical Corp Convertible Note 20 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 92,319	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(15,109)	[1]
ENDING BALANCE	$ 77,210	[1]
SHARES HELD | shares	150,000	[1]
Intra Op Medical Corp Convertible Note 21 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 215,412	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(35,255)	[1]
ENDING BALANCE	$ 180,157	[1]
SHARES HELD | shares	350,000	[1]
Intra Op Medical Corp Series C Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 0	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	0	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	26,856,187	[1]
Intra Op Medical Corp Term Note [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 1,230,926	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(201,458)	[1]
ENDING BALANCE	$ 1,029,468	[1]
SHARES HELD | shares	2,000,000	[1]
Revasum Inc C D I [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 3,520,496	[1],[2]
PURCHASE/MERGER	0	[1],[2]
INTEREST	0	[1],[2]
SALES/MATURITY/EXPIRATION	0	[1],[2]
REALIZED GAIN (LOSS)	0	[1],[2]
CHANGE IN APPRECIATION/(DEPRECIATION)	2,860,511	[1],[2]
ENDING BALANCE	$ 6,381,006	[1],[2]
SHARES HELD | shares	39,774,889	[1],[2]
Silicon Genesis Corp Common Stock [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 111	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(7,966)	[1]
REALIZED GAIN (LOSS)	(161,080)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	168,935	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Common Warrants [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 1	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(1)	[1]
REALIZED GAIN (LOSS)	(6,677)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	6,677	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Series 1 G Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 306,671	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(417,972)	[1]
REALIZED GAIN (LOSS)	(3,462,620)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	3,573,921	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Series 1 H Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 35,529	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(7,241)	[1]
REALIZED GAIN (LOSS)	(929,654)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	901,366	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Series 1 D Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 2,552	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(7,351)	[1]
REALIZED GAIN (LOSS)	(424,549)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	429,348	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Series 1 E Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 320,592	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(49,292)	[1]
REALIZED GAIN (LOSS)	(2,323,111)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	2,051,811	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Series 1 F Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 70,806	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(7,885)	[1]
REALIZED GAIN (LOSS)	(448,504)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	385,583	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
Silicon Genesis Corp Series 1 C Preferred Stock [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 962	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	(716)	[1]
REALIZED GAIN (LOSS)	(108,802)	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	108,556	[1]
ENDING BALANCE	$ 0	[1]
SHARES HELD | shares	0	[1]
U C T Coatings Inc Common Stock [Member] | Advanced Materials [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 337,500
PURCHASE/MERGER	0
INTEREST	0
SALES/MATURITY/EXPIRATION	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	(134,828)
ENDING BALANCE	$ 202,672
SHARES HELD | shares	1,500,000
Wrightspeed Inc Common Stock [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 546	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(260)	[1]
ENDING BALANCE	$ 286	[1]
SHARES HELD | shares	69,102	[1]
Wrightspeed Inc Convertible Note [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 65,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(36,000)	[1]
ENDING BALANCE	$ 29,000	[1]
SHARES HELD | shares	200,000	[1]
Wrightspeed Inc Convertible Note 1 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 60,125	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(33,300)	[1]
ENDING BALANCE	$ 26,825	[1]
SHARES HELD | shares	185,000	[1]
Wrightspeed Inc Convertible Note 2 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 21,125	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(11,700)	[1]
ENDING BALANCE	$ 9,425	[1]
SHARES HELD | shares	65,000	[1]
Wrightspeed Inc Convertible Note 3 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 4 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 5 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 6 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 227,500	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(126,000)	[1]
ENDING BALANCE	$ 101,500	[1]
SHARES HELD | shares	700,000	[1]
Wrightspeed Inc Convertible Note 7 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 8 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 9 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 10 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 43,875	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(24,300)	[1]
ENDING BALANCE	$ 19,575	[1]
SHARES HELD | shares	135,000	[1]
Wrightspeed Inc Convertible Note 11 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 53,625	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(29,700)	[1]
ENDING BALANCE	$ 23,925	[1]
SHARES HELD | shares	165,000	[1]
Wrightspeed Inc Convertible Note 12 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 40,625	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(22,500)	[1]
ENDING BALANCE	$ 18,125	[1]
SHARES HELD | shares	125,000	[1]
Wrightspeed Inc Convertible Note 13 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 0	[1]
PURCHASE/MERGER	100,000	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(85,500)	[1]
ENDING BALANCE	$ 14,500	[1]
SHARES HELD | shares	100,000	[1]
Wrightspeed Inc Convertible Note 14 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 81,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(45,000)	[1]
ENDING BALANCE	$ 36,250	[1]
SHARES HELD | shares	250,000	[1]
Wrightspeed Inc Convertible Note 15 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Convertible Note 16 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Convertible Note 17 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Convertible Note 18 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 1,601,930	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(887,223)	[1]
ENDING BALANCE	$ 714,707	[1]
SHARES HELD | shares	4,929,015	[1]
Wrightspeed Inc Convertible Note 19 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 243,750	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(135,000)	[1]
ENDING BALANCE	$ 108,750	[1]
SHARES HELD | shares	750,000	[1]
Wrightspeed Inc Convertible Note 20 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 292,500	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(162,000)	[1]
ENDING BALANCE	$ 130,500	[1]
SHARES HELD | shares	900,000	[1]
Wrightspeed Inc Convertible Note 21 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 121,875	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(67,500)	[1]
ENDING BALANCE	$ 54,375	[1]
SHARES HELD | shares	375,000	[1]
Wrightspeed Inc Convertible Note 22 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 130,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(72,000)	[1]
ENDING BALANCE	$ 58,000	[1]
SHARES HELD | shares	400,000	[1]
Wrightspeed Inc Convertible Note 23 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 341,250	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(189,000)	[1]
ENDING BALANCE	$ 152,250	[1]
SHARES HELD | shares	1,050,000	[1]
Wrightspeed Inc Convertible Note 24 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Convertible Note 25 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Convertible Note 26 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Convertible Note 27 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 390,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(216,000)	[1]
ENDING BALANCE	$ 174,000	[1]
SHARES HELD | shares	1,200,000	[1]
Wrightspeed Inc Convertible Note 28 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 455,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(252,000)	[1]
ENDING BALANCE	$ 203,000	[1]
SHARES HELD | shares	1,400,000	[1]
Wrightspeed Inc Convertible Note 29 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 650,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(360,000)	[1]
ENDING BALANCE	$ 290,000	[1]
SHARES HELD | shares	2,000,000	[1]
Wrightspeed Inc Convertible Note 30 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 130,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(72,000)	[1]
ENDING BALANCE	$ 58,000	[1]
SHARES HELD | shares	400,000	[1]
Wrightspeed Inc Convertible Note 31 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 97,500	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(54,000)	[1]
ENDING BALANCE	$ 43,500	[1]
SHARES HELD | shares	300,000	[1]
Wrightspeed Inc Convertible Note 32 [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 325,000	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(180,000)	[1]
ENDING BALANCE	$ 145,000	[1]
SHARES HELD | shares	1,000,000	[1]
Wrightspeed Inc Series A A Preferred [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 1,049,478	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(506,132)	[1]
ENDING BALANCE	$ 543,346	[1]
SHARES HELD | shares	60,733,693	[1]
Wrightspeed Inc Series A A Warrants [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 3,232	[1]
PURCHASE/MERGER	0	[1]
INTEREST	0	[1]
SALES/MATURITY/EXPIRATION	0	[1]
REALIZED GAIN (LOSS)	0	[1]
CHANGE IN APPRECIATION/(DEPRECIATION)	(1,523)	[1]
ENDING BALANCE	$ 1,709	[1]
SHARES HELD | shares	609,756	[1]
Total Affiliates And Controlled Investments [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	$ 39,349,502
INTEREST	148,983
REALIZED GAIN (LOSS)	(7,864,997)
CHANGE IN APPRECIATION/(DEPRECIATION)	3,320,924
ENDING BALANCE	34,407,004
Affiliates [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	337,500
INTEREST	0
REALIZED GAIN (LOSS)	0
CHANGE IN APPRECIATION/(DEPRECIATION)	(134,828)
ENDING BALANCE	202,672
Controlled Investments [Member]
Net Investment Income [Line Items]
BEGINNING BALANCE	39,012,002
INTEREST	148,983
REALIZED GAIN (LOSS)	(7,864,997)
CHANGE IN APPRECIATION/(DEPRECIATION)	3,455,752
ENDING BALANCE	$ 34,204,332
[1]Controlled Investments.[2]CDI: CHESS Depositary Interest